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GENETIC AND BIOCHEMICAL ANALYSES OF  
THE FLAVIVIRIDAE CAPSID PROTEINS 
 
Catherine Lucy Murray, Ph.D. 
The Rockefeller University 2007 
 
 The small, enveloped viruses of the family Flaviviridae are etiological 
agents of numerous important human and agricultural diseases including 
hepatitis C, yellow fever, and bovine viral diarrhea.  Efficient dissemination of 
these viruses is dependent on the production of infectious particles, thought to 
arise by budding of the capsid protein and associated genomic RNA through 
a host cell-derived lipid membrane outfitted with envelope glycoproteins.  The 
process of virion morphogenesis is not well understood, but the presumed 
involvement of numerous viral and cellular components makes it an attractive 
target for novel therapeutic drug design.  To investigate the early events of 
Flaviviridae particle assembly, we examined the properties of a major virion 
structural component, the viral capsid proteins.  Biochemical analysis of the 
bovine viral diarrhea virus (BVDV) capsid protein revealed a remarkably 
flexible molecule, capable of binding RNA with low affinity and low specificity 
in vitro.  The ability of BVDV capsid to functionally replace a nonspecific RNA 
condensing sequence in vivo suggests a mechanism for its role in virion 
assembly.  Hepatitis C virus (HCV) propagation in tissue culture has very 
recently become possible, allowing the role of the capsid (core) protein in the 
authentic viral life cycle to be studied for the first time.  We performed a 
comprehensive deletion and mutational analysis of the HCV core protein, 
confirming its importance for infectious virus production and identifying 
numerous residues essential for this activity.  Interestingly, investigation of the 
virion building blocks converged on a group of nonstructural proteins that may 
engineer the assembly process.  The infectivity of several defective HCV core 
mutants could be rescued by compensatory mutations in p7, NS2, and NS3, 
adding to accumulating evidence that these nonstructural proteins are 
important for virion morphogenesis.  The functional determinants of an 
analogous BVDV protein, uncleaved NS2-3, in infectious virus production 
were examined.  These studies of the Flaviviridae capsid proteins provide 
insights into the mechanisms of viral genome packaging and highlight the 
importance of nonstructural accessory factors in the initial steps of infectious 
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Chapter 1: Introduction 
Infectious disease continues to be a significant cause of morbidity and 
mortality for much of the world’s population.  The burden of these infections falls 
most heavily on the people of the developing world, where even a vaccine-
preventable disease such as yellow fever continues to kill over 30 000 people 
each year (207).  The continuing threat of viral disease has been highlighted in 
recent years by the HIV pandemic, the spread of West Nile virus to new 
environments, the emergence of severe-acute respiratory syndrome, and by 
increasing incidences of avian influenza virus transmission to humans.  
Numerous pathogens of immense human and agricultural impact are 
encompassed within the family Flaviviridae, a group of small, enveloped viruses 
that is divided into the genera Hepacivirus, Flavivirus, and Pestivirus (116). 
Hepatitis C virus (HCV), the sole member of the Hepacivirus genus, is a 
major etiological agent of liver disease, with an estimated 170 million people 
infected worldwide (222). Although about 20% of individuals exposed to the virus 
will spontaneously resolve the infection, the majority will become chronic carriers 
(65).  These carriers are at high risk for cirrhosis and hepatocellular carcinoma, 
as well as extrahepatic manifestations such as immune-complex disease and 
lymphomas (190).  In developed countries, HCV infection is the leading cause of 
liver transplantation (214).  There is no vaccine available to protect against HCV 
infection and the current therapy, a combination of interferon-α and the 
nucleoside analog ribavirin, is frequently not effective (116).   
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Flaviviruses, the insect vector-borne relatives of HCV, are the causative 
agents of numerous globally significant diseases.  Yellow fever virus (YFV), the 
first human virus discovered over a century ago, remains endemic in many parts 
of the world (207).  West Nile virus (WNV), dengue virus (DENV), and Japanese 
encephalitis virus (JEV) represent pathogens that are resurging and spreading to 
new environments (127).  Other Flaviviruses, including tick-borne encephalitis 
virus (TBEV), are highly problematic but less widespread (74).  Serious 
manifestations of Flavivirus infections include encephalitis, hemorrhagic fever, 
and death (127, 74). 
Pestiviruses infect wild and agriculturally important animals worldwide.  
These economically significant pathogens include bovine viral diarrhea virus 
(BVDV), classical swine fever virus (CSFV), and border disease virus (BDV) 
(143).  Pestivirus infection can lead to symptoms ranging from subclinical 
disease to hemorrhagic syndromes.  BVDV has an extremely high prevalence in 
cattle, with an average of 60-90% of animals infected during their lifetime (143).  
A major burden of these infections on the livestock industry results from virus-
induced infertility, fetal malformations, and stillbirths (143).  Complications of 
BVDV infection include the highly fatal mucosal disease, and the induction of an 
immunocompromised state, allowing colonization by opportunistic pathogens 
(143, 28).          
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Gene expression and replication 
The enveloped virions of the Flaviviridae contain a positive-sense, single-
stranded, RNA genome of approximately 9-12 kilobases (kb).  Binding of the 
virions to their cellular receptors results in endocytosis of the particle and a 
subsequent low-pH induced fusion event that releases the capsid protein and 
associated genomic RNA into the cytoplasm (Fig 1-1, ref 209, 39, 111).  The 
genomes, resembling cellular mRNAs, are directly translated on introduction into 
the cell.  For HCV and the Pestiviruses, translation is initiated at an internal 
ribosome entry site (IRES, ref 170, 210); for the Flaviviruses, translation is cap- 
dependent (116). None of the viral genomes are polyadenlyated, but instead 
have 3’ untranslated regions (UTRs) with conserved RNA structural elements 
(116).  Translation yields a polyprotein of approximately 3000 residues, which 
must be processed by viral and cellular proteases to liberate the individual viral 
proteins.  These proteins are sequentially designated NH2-C-E1-E2-p7-NS2-NS3-
NS4A-NS4B-NS5A-NS5B-COOH for Hepaciviruses, NH2-C-prM-E-NS1-NS2A-
NS2B-NS3-NS4A-NS4B-NS5-COOH for Flaviviruses, and NH2-Npro-C-Erns-E1-E2-
p7-NS2-NS3-NS4A-NS4B-NS5A-NS5B-COOH for Pestiviruses (Fig 1-2).  
Structural proteins, which make up the physical virion, are found in the amino-
terminal region of the polyprotein and are predominantly processed by cellular 
enzymes such as signal peptidase.  They consist of capsid (C), and the envelope 
proteins.  The nonstructural (NS) proteins comprise the remainder of the 











polyprotein and are liberated primarily by the major viral protease NS3 (10, 224, 
34) along with its cofactor NS4A (56, 224) or NS2B (Flaviviruses , ref 34).  
The nonstructural proteins NS3 to NS5B (NS1 to NS5 in Flaviviruses) 
associate to form the replicase complex.  Replication is entirely cytoplasmic and 
occurs in close association with modified intracellular membranes, likely derived 
from the endoplasmic reticulum (ER, ref 144).  NS5B and NS5 (Flaviviruses) 
constitute the viral RNA-dependent RNA polymerases, which, as part of the 
replicase complex, catalyze the asymmetric accumulation of genomic, plus-
strand, over minus-strand RNA (17, 236, 198).  In addition to protease activity, 
the NS3 proteins possess helicase (217, 218, 131) and nucleoside 
triphosphatase (NTPase, ref 194, 197, 221) activities essential for RNA 
replication.  HCV and Pestivirus NS4B and NS5A proteins, as well as Flavivirus 
NS4A and NS4B proteins, have as yet undefined but essential roles in RNA 
replication.  Accumulating evidence indicates that nonstructural proteins p7 to 
NS3 (NS2A to NS3 in Flaviviruses) are involved in infectious virus production 
(116).   
 
Infectious virus production 
The enveloped virions of the Flaviviridae are thought to arise by budding 
of the capsid and associated genomic RNA into an ER-derived membrane 
studded with envelope glycoproteins.  These virions then egress via the cellular 
secretory pathway, and are released into the extracellular milieu without lysis 
Pestivirus
Flavivirus
Npro C  Erns  E1   E2   p7    NS2    NS3   4A  4B   NS5A          NS5B
C   prM    E     NS1  NS2A  2B       NS3     NS4A  NS4B       NS5
Hepacivirus




































Fig 1-2.  Genomes (A) and predicted polyprotein topologies 
(B) of the Flaviviridae.  See text for details.
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of the host cell.  The preponderance of information regarding Flaviviridae 
infectious particle morphogenesis comes from studies of classical Flaviviruses.  
Investigation of HCV assembly has been extremely limited since, until very 
recently, tissue culture systems that allowed replication of the viral genome did 
not support infectious particle production.  
 
Flaviviruses 
The assembly pathways of the members of the genus Flavivirus are the 
best characterized in the Flaviviridae family.  In addition to the genomic RNA and 
a host-derived lipid bilayer, Flavivirus virions are composed of the capsid protein, 
the envelope protein (E), and a fragment of the precursor to M (prM) protein.  The 
capsid protein is the first product encoded by the viral genome, and on 
translation, targets the nascent polyprotein to the ER membrane via a signal 
sequence in its carboxy-terminus (129).  Processing of capsid from the 
polyprotein depends on the accumulation of the viral protease NS3 and its NS2B 
cofactor (NS2B-3).  Cleavage of the capsid protein from its membrane anchor by 
the cytosolic viral protease is a prerequisite for signal peptidase cleavage of the 
amino-terminus of the first glycoprotein, prM, on the luminal side of the ER 
membrane (119, 191, 192, 6).  After cleavage from its membrane anchor, capsid 
remains associated with membranes through exposed hydrophobic sequences 
and dimerizes to form the functional subunit of assembly (124, 97, 89, 50).  High-
resolution structures of DENV and WNV capsid proteins (124, 50) indicate that 
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these helix-rich molecules also have numerous surface-exposed basic residues, 
available for interactions with RNA.  Although a specific encapsidation signal in 
the Flavivirus genome has not been identified, capsid may have higher affinity for 
the 5’ and 3’ UTRs (96).  Interaction of capsid and RNA presumably leads to the 
formation of a nucleocapsid, although these structures are rarely discernable in 
infected cells and do not have a defined symmetry in cryo-electronmicroscopy 
(cryo-EM) image reconstructions of the virus particles (233, 230, 101, 145).  
Although these results indicate that symmetrically ordered nucleocapsids are not 
formed during assembly, detergent treatment of TBEV particles releases capsid-
RNA complexes (97).  It has been suggested that capsid may interact with RNA 
in a manner resembling histones, instead of forming an ordered shell (50).   
Surrounding the capsid-RNA complex is a host-derived lipid membrane 
outfitted with membrane glycoproteins.  These glycoproteins, prM and E, 
immediately follow capsid in the polyprotein, are ER-associated via 
transmembrane domains, and heterodimerize soon after synthesis (232, 121).  
Dimerization allows prM to chaperone the folding of E, which contains the 
receptor binding and fusion peptide activities (121, 4).  prM functions to protect 
the fusogenic E protein during egress of particles through the low pH 
compartments of the secretory pathway (79, 126).  In the final Golgi 
compartment, prM is cleaved to pr and M by the host enzyme furin, allowing E to 
homodimerize (188, 167, 232).  The resulting mature, infectious virions are 
released from vesicles at the cell surface (188).  The crystal structures of TBEV, 
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DENV, and WNV E protein ectodomains have been solved, and show elongated 
dimers with the fusion peptide of each monomer buried through contacts with the 
adjacent molecule (167, 234, 91).  A structure of the DENV E protein at low pH 
showed a trimer, with the fusion peptides aligned and exposed at its tip (141).      
Budding of the capsid-RNA complex into the ER lumen is driven by lateral 
associations between the envelope proteins (146).  Consistent with this, subviral 
particles, containing no capsid or RNA, are produced in natural infections and 
can be induced by overexpression of the glycoproteins alone in cells (5).  Cryo-
EM image reconstruction has been used to determine the structures of TBEV 
subviral particles, as well as of immature DENV and YFV particles, and mature 
DENV and WNV virions (Fig 1-3).  Experimentally produced immature DENV and 
YFV particles retain the prM cap on the E fusion peptide and presumably mimic 
virions transiting the secretory pathway.  The structures of these particles 
demonstrate prominent spikes emanating from the membrane (Fig 1-3, ref 232).  
These spikes consist of E protein trimers with their fusion peptides aligned at the 
surface (141).  In the immature particles, prM protects the fusion peptides of the 
particles that are otherwise primed for fusion (232).  In contrast to the 
conspicuous surface projections of the immature virion, the mature virus particle 
has a drastically different arrangement of the glycoproteins (Fig 1-3). The E 
protein was found to lie parallel to the lipid membrane in an unusual herringbone 
array, completely covering the bilayer in a smooth, proteinaceous coat (101, 





Fig 1-3.  Structures of Flavivirus particles. 
(A) Mature DENV virion (101).  (B) TBEV subviral 
particle (58).  (C)  Immature DENV particle (232).
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domains, or between the capsid protein and the envelope proteins.  Subviral 
particles resembled mature particles in the prone conformation of the E protein, 
but exhibited a classical T=1 symmetry rather than the herringbone array (Fig 1-
3, 58).  The mechanisms by which prM cleavage in the Golgi leads to the 
massive glycoprotein rearrangements on the virion surface are not known (232).   
Although structural insights have elucidated many aspects of Flavivirus 
maturation and egress, the early events of virion assembly and its regulation are 
poorly understood.  Several nonstructural proteins have been shown to be 
important for assembly or budding of the nucleocapsid.  Mutations in YFV NS2A, 
a hydrophobic protein of unclear function, were shown to inhibit release of 
genome-containing, but not subviral particles (103). Compensatory mutations in 
the NS3 helicase domain overcame this defect, suggesting a functional 
interaction between NS2A and NS3 might be important for infectivity (103).  The 
nonstructural proteins of the replicase complex may also function in assembly 
regulation, since it has been observed that only replication-competent genomes 
are substrates for packaging (95).  It is likely that numerous cellular factors are 
also involved in virion assembly and egress.  As well as the host proteases signal 
peptidase (129) and furin (188), a kinase, c-Yes, has been found to be essential 
for release of WNV particles, possibly reflecting a role for this protein in vesicular 




Pestivirus assembly is not as well understood as Flavivirus 
morphogenesis.  The envelope of a Pestivirus virion is studded with three 
glycoproteins, Erns (ribonuclease secreted), E1, and E2 (205).  The interior of the 
particle contains the capsid protein (C) and the genomic RNA (205).  Unlike the 
other Flaviviridae, the initial translation product of the Pestivirus genome is not 
structural, but a nonstructural protein, Npro. Npro is an autoprotease that mediates 
a single cleavage at the amino-terminus of the capsid protein (223, 177).  A 
signal sequence in the carboxy-terminus of capsid targets the nascent 
polyprotein to the membrane, initiating a dual processing event by host enzymes.  
Signal peptidase cleaves capsid from Erns in the ER lumen (178), and signal 
peptide peptidase (SPP) performs an additional processing event within the 
capsid membrane anchor (78).  The highly basic nature of the mature capsid 
protein indicates that it likely functions to bind and package the RNA genome, 
although little is known about its role in this respect. 
By analogy to the Flaviviruses, Pestivirus nucleoprotein complexes are 
presumed to bud into the ER lumen, concurrently acquiring the envelope 
glycoproteins.  Observation of particles within the ER by electron microscopy, as 
well as the absence of glycoprotein expression on the cell surface, supports this 
hypothesis (70, 71, 219, 75).  The envelope proteins, Erns, E1, and E2, 
immediately follow capsid in the polyprotein and are targeted to the membrane by 
signal sequences in capsid and E1 (178).  Signal peptidase-mediated cleavages 
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are thought to create an Erns-E1-E2 precursor, from which E2 is rapidly liberated 
(178).  Cleavage of Erns from E1 is slow and may occur in a post-ER 
compartment analogous to prM cleavage in Flaviviruses (178).  After separation 
from the polyprotein, E1 and E2 rapidly associate with the chaperone calnexin 
(27).  In the virion the envelope proteins assume the form of disulfide-linked E2 
homodimers and E1-E2 heterodimers (205).  Erns is also a major component of 
the virion (205).  This heavily glycosylated protein does not have a typical 
transmembrane domain and is thought to incorporate into particles via an 
unusual membrane anchor of unknown structure (59); it is also secreted in a 
soluble form from infected cells (178).   The most striking feature of the Erns 
protein is that it possesses ribonuclease activity (181).  This enzymatic activity 
has been shown to be essential for virulence in vivo, but not required for growth 
in cultured cells (139).  Although its mechanism of action is not known, it may 
play a role in immune evasion, either by inducing apoptosis of immune cells (110, 
28, 59) or by inhibiting toll-like receptor (TLR-3) activation by degrading its RNA 
ligand.  
Nonstructural proteins have also been shown to function in Pestivirus 
morphogenesis.  p7 is a small integral membrane protein that is incompletely 
processed from E2 by signal peptidase (54).  Although neither p7, nor E2-p7 can 
be detected in virus particles, p7 is absolutely required for infectivity (206, 76).  
Similarities have been noted between p7 and viroporins, a class of small, 
hydrophobic, virally encoded proteins that act as ion channels (73).  Consistent 
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with this hypothesis, p7 was found to oligomerize and to form ion-conductive 
channels when overexpressed in mammalian cells (73).  The role of this putative 
ion channel activity in Pestivirus morphogenesis, however, remains controversial.  
Reminiscent of the proposed functional relationship between Flavivirus NS2A 
and NS3 proteins (103), we have found evidence that Pestivirus NS2 and NS3 
proteins are essential for virion formation (2).   
 
Hepaciviruses 
The sole member of the Hepacivirus genus, HCV, has only recently been 
propagated in tissue culture and studies of its assembly are therefore in their 
infancy.  Analogies with Flaviviruses and Pestiviruses, as well as characterization 
of virions isolated from patient sera, have suggested that envelope proteins E1 
and E2, along with the capsid protein, genomic RNA, and a host-derived lipid 
bilayer constitute the infectious particle (68, 227).  The capsid protein, termed 
core, is the first product encoded by the open reading frame.   It is liberated from 
the polyprotein by the host enzymes signal peptidase and SPP in a manner 
analogous to the Pestiviruses (180, 133).  Studies of core protein in vitro and in 
overexpression systems have suggested that it interacts homotypically to form 
dimers and higher order structures, including nucleocapsid-like particles (25, 130, 
105, 99).  Associations of core with the envelope glycoproteins E1 and E2, as 
well as with RNA, have also been reported (151, 118, 12, 180, 43, 187).  When 
overexpressed in cells, core is found to localize to cholesterol and triglyceride-
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rich storage granules termed lipid droplets (7).  Processing of core by SPP is a 
prerequisite for this association (133).  Recent studies of infected cells suggest 
that lipid droplets and their associated membranes are the only subcellular 
compartments in which core accumulates, leading to speculation that these fatty 
deposits may be sites of particle assembly (176).  Surprisingly, envelope proteins 
were not found to colocalize with core in infected cells (176). 
In the infectious virion, E1 and E2 are presumably displayed on the 
particle surface, allowing E2 to mediate interactions with the primary entry 
receptor, CD81 (160).  Transient expression of the structural region has been 
used to define a putative pathway of HCV glycoprotein maturation.  After 
cotranslational insertion of the polyprotein into the ER membrane, signal 
peptidase rapidly processes E1 from E2-p7-NS2, the precursor from which E2 is 
subsequently cleaved (68).  E1 and E2 are thought to associate rapidly with the 
chaperone calnexin (52).  E2 folds quickly, attaining its final conformation before 
it is cleaved from the E2-p7-NS2 precursor (52).  E2 then interacts with the 
slower folding E1 to provide additional chaperone help; in the absence of E2, E1 
cannot attain its proper conformation (51).  Experimentally produced 
psuedoparticles (HCVpp), in which E1 and E2 glycoproteins decorate a defective 
retrovirus core, have been used to study the determinants of envelope protein 
function (11).  Glycosylation of both E1 and E2 ectodomains has been found to 
be important for folding and heterodimerization of the envelope proteins, and for 
the assembly and release of HCVpp (116). 
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As in Pestiviruses, nonstructural proteins p7 and NS2 are essential for 
HCV infectious virus production (179, 90). Both p7 and NS2 appear to act early in 
assembly and possibly interact with each to accomplish their functions in 
morphogenesis (90).   Similar to BVDV p7, the HCV protein has been found to 
oligomerize into ion conductive channels in vitro (72). The relevance of the in 
vitro ion channel activity to p7 functions in morphogenesis is not yet resolved 
(90).  
 
HCV infectious system 
Almost two decades after the discovery of HCV as the major causative 
agent of non-A non-B hepatitis (38), the entire infectious cycle of the virus has 
been recapitulated in tissue culture for the first time (115, 215, 235).  HCV cell 
culture infectious systems (HCVcc) take advantage of a unique genotype 2a 
patient isolate, Japanese fulminant hepatitis-1 (JFH-1), which both replicates to 
high levels and supports the release of infectious particles (92, 215, 235).   
The efficient replication of JFH-1 has been hypothesized to be central to 
its singular phenotype (9).  Previously, successful replication of HCV genomes in 
culture required the accumulation of adaptive mutations.  These mutations, 
primarily found in NS3, NS4B and NS5A, were isolated by propagation of 
genomes containing selectable markers (9, 21, 120).  It was speculated that 
these mutations, as well as increasing replication by unknown mechanisms, 
might also inhibit infectious virus production, since genomes containing such 
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changes were not infectious in chimpanzees (29).  Interestingly, several of the 
adaptive mutations altered the phosphorylation state of NS5A, suggesting this 
nonstructural protein may be important in the regulation of infectivity (55).  JFH-1 
does not require the accumulation of adaptive mutations in order to replicate in 
cultured cells (92).  The determinants of this robust replication, and of its 
infectivity, are not known.     
JFH-1 infectivity could be enhanced by substitution of its structural 
proteins with those of another genotype 2a isolate, J6, leading to a chimeric 
genome termed J6/JFH (115).  This chimeric genome was slightly more 
infectious than JFH-1, reaching titers of approximately 105 infectious units/ml 
(115).  The advent of the cell culture infectious system allows the authentic HCV 
viral life cycle to be studied for the first time, and the long enigmatic process of 
HCV infectious virion production to begin to be unraveled. 
 
Objectives 
 The processes of virion assembly and secretion are presumed to require a 
careful orchestration of numerous viral and cellular interacting factors.   The 
pathways of infectious virion production, therefore, are rich in targets for novel 
therapeutic drug development.  Furthermore, an understanding of virion 
components and the determinants of virus construction can impact the design of 
immunogenic particles for vaccines.   
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The requirements and mechanisms of Flaviviridae infectious virus 
production are the subject of this thesis.  In the hopes of understanding the 
earliest events in assembly, we investigated a particle building block, the viral 
capsid proteins.  Through biochemical analysis, the BVDV capsid protein was 
determined to be an unusually flexible RNA binding protein, capable of nucleic 
acid condensation activity in vivo.  This curiously unconstrained RNA packaging 
mechanism may be a general feature of the Flaviviridae, as discussed in chapter 
3.  With the advent of the tissue culture infectious system, a study of the HCV 
core protein in the context of an authentic viral life cycle could be attempted for 
the first time.  As reported in chapter 4, we performed a comprehensive deletion 
and mutagenesis study of the HCV core protein, identifying numerous residues 
essential for infectious virus production.  Studies of the virion building blocks 
converged on a group of nonstructural proteins that may represent the assembly 
architects.  In collaboration with Eugene Agapov, a nonstructural precursor, NS2-
3, was found to be essential for BVDV infectivity; the determinants of its activity 
are investigated in chapter 5.  Remarkably, studies of HCV core protein 
uncovered roles for the same nonstructural proteins in Hepacivirus 
morphogenesis; mutations in this region were found to rescue the infectivity of 
defective core mutants.  These new insights into the early events of Flaviviridae 
infectious particle production will hopefully add to the understanding of this 




Chapter 2:  Materials and Methods 
Cell culture. Cells were grown at 37°C in 5% CO2. 
BHK 21 (Baby hamster kidney) cells were propagated in modified Eagle’s 
medium (MEM, Invitrogen, Carlsbad, CA) supplemented with 7.5% fetal bovine 
serum (FBS, Invitrogen).   
Huh-7.5 (Human hepatoma) cells were propagated in Dulbecco’s modified 
Eagle’s medium (DMEM, Invitrogen) containing sodium pyruvate, 10 mM 
nonessential amino acids, and 10% FBS (Invitrogen).   
MDBK (Madin-Darby bovine kidney) cells were propagated in DMEM 
supplemented with sodium pyruvate and 10% horse serum (HS, Invitrogen).  
 
Plasmid constructs.  Plasmids were constructed by standard methods.  PCR 
fragments were amplified using Pfu Ultra High Fidelity DNA polymerase 
(Stratagene, La Jolla, CA) with 30 cycles of denaturing at 95°C for 30 sec, 
annealing at 55-65°C for 30 sec, and elongation at 72°C for 1 min per kb.   
Constructs were verified by restriction enzyme digestion and sequencing of PCR 
amplified segments.  Descriptions of the cloning strategies are provided below.  
 
BVDV capsid protein expression constructs 
GST-C84.  Nucleotides (nt) 890 to 1141 of pBeloBac11/NADL, a bacterial 
artificial chromosome vector (Invitrogen) encoding the full-length BVDV strain 
NADL genome (2), were PCR amplified using primers RU-2549 (5’-
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CGCGGATCCTCAGACACGAAAGAAGAGGGAG-3’) and RU-2550 (5’-
CCGCTCGAGTCATTTTTCCAGTTTCTTGCGTGATTC-3’).  RU-2549 engineered 
a BamHI site upstream of capsid, keeping it in-frame with GST.  RU-2550 
engineered a stop codon immediately downstream of capsid amino acid 84 and 
an XhoI site following the stop. The PCR product was digested with BamHI/XhoI 
and ligated to the 4757 base-pair (bp) fragment of pGEX-6P-1 (GE Healthcare, 
Piscataway, NJ) digested with the same enzymes.   
       
GST-C87.  Nucleotides 890 to 1150 of pBeloBac11/NADL were PCR amplified 
using primers RU-2549 (5’-CGCGGATCCTCAGACACGAAAGAAGAGGGAG-3’) 
and RU-4453 (5’-CCGCTCGAGTCACAACAATGCTTTTTCCAGTTTCTTG-3’). 
RU-4453 engineered a stop codon immediately downstream of capsid amino acid 
87 and an XhoI site following the stop.  The PCR product was digested with 
BamHI/XhoI and ligated to the 4757 bp fragment of pGEX-6P-1 (GE Healthcare) 
digested with the same enzymes.   
 
GST-C90.  Nucleotides 890 to 1159 of pBeloBac11/NADL were PCR amplified 
using RU-2549 (5’-CGCGGATCCTCAGACACGAAAGAAGAGGGAG-3’) and RU-
4658 (5’-CCGCTCGAGTCATGCCCACGCCAACAATGCTTT-3’). RU-4658 
engineered a stop codon immediately downstream of capsid amino acid 90 and 
an XhoI site following the stop.  The PCR product was digested with BamHI/XhoI 
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and ligated to the 4757 bp fragment of pGEX-6P-1 (GE Healthcare) digested with 
the same enzymes.   
 
Sindbis plasmid constructs 
The Sindbis/luc (pToto1101/luc) backbone encodes a wild-type Sindbis virus 
cDNA with firefly luciferase (1653 nt) inserted within nsP3 (19).  Plasmids were 
propagated in DH5α cells. 
 
Sindbis/luc CΔ2-96. Nucleotides 8471 to 9302 of Sindbis/luc were amplified with 
RU-8548 (5’-GGATTTTGATGCAATCATAG-3’) and RU-8556 (5’-CTCTTTCCGG 
GTTTGGGTTTCATGGTGGTGGTGTTGTAG-3’).  Nucleotides 9588 to 10085 of 
Sindbis/luc were amplified with RU-8555 (5’-CTACAACACCACCACC 
ATGAAACCCAAACCCGGAAAGAG-3’) and RU-8549 (5’-CTTCTGTCCCTTCC 
GGGGTC-3’).  Primary PCR products were assembled by amplification with 
flanking primers RU-8548 and RU-8549.  PCR products were digested with 
HpaI/AatII and ligated to the 14211 bp fragment of Sindbis/luc digested with the 
same enzymes. 
 
Sindbis/luc CΔ50-96. Nucleotides 8471 to 9302 of Sindbis/luc were amplified with 
RU-8548 and RU-8560 (5’-CTCTTTCCGGGTTTGGGTTTGACGGCTGTGGTCA 
GTTGC-3’). Nucleotides 9588 to 10085 of Sindbis/luc were amplified with RU-
8559 (5’-GCAACTGACCACAGCCGTCAAACCCAAACCCGGAAAGAG-3’) and 
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RU-8549. Primary PCR products were assembled by amplification with flanking 
primers RU-8548 and RU-8549.  PCR products were digested with HpaI/AatII 
and ligated to the 14211 bp fragment of Sindbis/luc digested with the same 
enzymes. 
 
Sindbis/luc CΔ72-96.   Nucleotides 8471 to 9512 of Sindbis/luc were amplified 
with RU-8548 and RU-8562 (5’-CTCTTTCCGGGTTTGGGTTTCTGGCGCGGT 
GGCGGGCGTG-3’). Nucleotides 9588 to 10085 of Sindbis/luc were amplified 
with RU-8561 (5’-CACGCCCGCCACCGCGCCAGAAACCCAAACCCGGAAA 
GAG-3’) and RU-8549. Primary PCR products were assembled by amplification 
with flanking primers RU-8548 and RU-8549.  PCR products were digested with 
HpaI/AatII and ligated to the 14211 bp fragment of Sindbis/luc digested with the 
same enzymes. 
 
Sindbis/luc CΔ2-96/BVDV1-84.  Nucleotides 890 to 1141of pBeloBac11/NADL 
were PCR amplified using primers RU-8727 (5’-TCAGACACGAAAGAAGAGGG-
3’) and RU-8564 (5’-CTCTTTCCGGGTTTGGGTTTTTTTTCCAGTTTCTTG 
CGTG-3’).  Primer RU-8564 creates the junction between NADL nt 1141 and 
Sindbis nt 9588.  Nucleotides 8471 to 9302 of Sindbis/luc were amplified with 
RU-8548 and RU-8725 (5’-CCCTCTTCTTTCGTGTCTGACATGGTGGTG 
GTGTTGTAG-3’).  RU-8725 creates the junction between Sindbis/luc nt 9302 
and NADL nt 890.  Primary PCR products were assembled using RU-8548 and 
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RU-8564.  Nucleotides 9588 to 10229 of Sindbis/luc were amplified with RU-8550 
(5’-AAACCCAAACCCGGAAAGAG-3’) and RU-8773 (5’-GTAGGCCTCATGGT 
TCACG-3’).  This PCR product was assembled with the secondary PCR product 
using RU-8748 and RU-8773.  Final PCR products were digested with HpaI/AatII 
and ligated to the 14211 bp fragment of Sindbis/luc digested with the same 
enzymes. 
 
Sindbis/luc CΔ2-96/BVDV1-90. Nucleotides 890 to 1159 of pBeloBac11/NADL 
were PCR amplified using primers RU-8727 and RU-8565 (5’-CTCTTTCCGGG 
TTTGGGTTTTGCCCACGCCAACAATGC-3’).  Primer RU-8565 creates the 
junction between NADL nt 1159 and Sindbis/luc nt 9588.  Nucleotides 8471 to 
9302 of Sindbis/luc were amplified with RU-8548 and RU-8725. RU-8725 creates 
the junction between Sindbis/luc nt 9302 and NADL nt 890. Primary PCR 
products were assembled using RU-8548 and RU-8565. Nucleotides 9588 to 
10229 of Sindbis/luc were amplified with RU-8550 and RU-8773. This PCR 
product was assembled with the secondary PCR product using RU-8748 and 
RU-8773. Final PCR products were digested with HpaI/AatII and ligated to the 
14211 bp fragment of Sindbis/luc digested with the same enzymes. 
 
Sindbis/luc CΔ50-96/BVDV35-83. Nucleotides 992 to 1138 of pBeloBac11/NADL 
were PCR amplified using primers RU-8728 (5’-AGCAAAACTAAACCTCCGG-3’) 
and RU-8570 (5’-CTCTTTCCGGGTTTGGGTTTTTCCAGTTTCTTGCGTGATTC-
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3’).  Primer RU-8570 creates the junction between NADL nt 1138 and Sindbis/luc 
nt 9588.  Nucleotides 8471 to 9446 of Sindbis/luc were amplified with RU-8548 
and RU-8723 (5’-CCGGAGGTTTAGTTTTGCTGACGGCTGTGGTCAGTTGC-3’). 
RU-8723 creates the junction between Sindbis/luc nt 9446 and NADL nt 992. 
Primary PCR products were assembled using RU-8548 and RU-8570. 
Nucleotides 9588 to 10229 of Sindbis/luc were amplified with RU-8550 and RU-
8773. This PCR product was assembled with the secondary PCR product using 
RU-8748 and RU-8773.  Final PCR products were digested with HpaI/AatII and 
ligated to the 14211 bp fragment of Sindbis/luc digested with the same enzymes. 
 
Sindbis/luc CΔ72-96/BVDV54-83. Nucleotides 1049 to 1138 of 
pBeloBac11/NADL were PCR amplified using primers RU-8729 (5’-AGGAA 
GAAGGGAAAAACCAAG-3’) and RU-8572 (5’-CTCTTTCCGGGTTTGGGTTTT 
TCCAGTTTCTTGCGTGATTC-3’).  Primer RU-8572 creates the junction between 
NADL nt 1138 and Sindbis/luc nt 9588. Nucleotides 8471 to 9512 of Sindbis/luc 
were amplified with RU-8548 and RU-8726 (5’-CTTGGTTTTTCCCTTC 
TTCCTCTGGCGCGGTGGCGGGCGTG-3’). RU-8726 creates the junction 
between Sindbis/luc nt 9512 and NADL nt 1049. Primary PCR products were 
assembled using RU-8548 and RU-8572. Nucleotides 9588 to 10229 of 
Sindbis/luc were amplified with RU-8550 and RU-8773. This PCR product was 
assembled with the secondary PCR product using RU-8748 and RU-8773. Final 
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PCR products were digested with HpaI/AatII and ligated to the 14211 bp 
fragment of Sindbis/luc digested with the same enzymes. 
 
HCV plasmid constructs 
These genomes are based on the J6/JFH chimeric genotype 2a sequence (115), 
or its derivative J6/JFH(p7Rluc2A), in which a Renilla luciferase-2A sequence is 
inserted between p7 and NS2 (90).  ΔE1E2 genomes contain an in-frame 
deletion of amino acids 217 to 567 (J6/JFH polyprotein numbering), 
encompassing the majority of the E1 and E2 proteins (90).  GND genomes 
contain a mutation of amino acid D2760 to N (J6/JFH polyprotein numbering), 
abolishing the conserved RNA-dependent RNA polymerase motif, GDD (90). 
Plasmids were propagated in DH5α cells. 
 
J6/JFH and J6/JFH(p7Rluc2A) with deletions and substitutions.  Deletions or 
amino acid substitutions were introduced by PCR amplification of the core-coding 
region of J6/JFH with primers containing the desired changes.  Primary PCR 
products containing the engineered mutations were assembled by amplification 
with flanking primers RU-6009 (5’-CGACGGCCAGTGAATTCTAATACG-3’) and 
RU-5743 (5’-ATGCCATGCGGTGTCCAG-3').  PCR products were digested with 
EcoRI/KpnI and ligated to the 12073 bp fragment of J6/JFH(p7Rluc2A) or the 
11074 bp fragment of J6/JFH digested with the same enzymes. 
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J6/JFH with p7, NS2, NS3, and core mutations.  Isolated compensatory 
mutations were reengineered into wild-type J6/JFH and the parental core 
mutants.  To facilitate cloning, a wild-type J6/JFH sequence modified to include 
unique, silent restriction sites at positions 2392 (BglII) and 2955 (NotI) (termed 
J6/JFH1.1) was used.  Compensatory mutations were engineered by PCR 
amplification of the appropriate J6/JFH1.1 sequences with primers containing the 
desired changes.  Primary PCR products were assembled by amplification with 
flanking primers RU-6020 (5’-TATGTGGGAG GGGTTGAG-3’) and RU-5721 (5’-
GCTACCGA GGGGTTAAGCACT-3’).  PCR products were digested with 
BglII/NotI (p7 mutants) or NotI/SpeI (NS2 and NS3 mutants) and ligated to the 
11804 bp BglII/NotI fragment or the 11219 bp NotI/SpeI fragment of J6/JFH1.1.  
To engineer the compensatory changes into the parental core mutants, the 
11074 bp EcoRI/KpnI fragment of the nonstructural protein mutant was ligated to 
the 1290 bp EcoRI/KpnI fragment of the appropriate core protein mutant.   
 
BVDV plasmid constructs 
The backbone for the following constructs is the bacterial artificial chromosome 
vector pBeloBAC11 (Invitrogen). This single copy vector was used since 
plasmids encoding portions of the BVDV genome are toxic and unstable in 
bacterial cells.  For large-scale plasmid preparation, the smallest colonies were 
picked from freshly transformed electrocompetent DH10B cells.  Overnight 
cultures were grown from 8 h cultures diluted into 500 ml Terrific Broth with 12.2 
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µg/ml chloramphenicol.  Flasks were covered with two kimwipes, not foil, to allow 
sufficient aeration. Plasmid was recovered by alkaline lysis followed by single 
banding on cesium chloride gradient. 
 
Npro-NS2/sg: (Constructed by Eugene Agapov) This genome contains the 5’ NTR 
to NS2 region of the NADL Jiv 90- genome, followed by the encephalomyocarditis 
virus (EMCV) IRES, Npro, NS3 and the remainder of the NADL sequence.  A 
similar strategy as for Npro-E2/sg (2) was used except that nucleotides 4973-5152 
of pACNR/NADL were amplified and digested with Bsp120I and NsiI.  The stop 
codon is at R1589 (nt 5152, at the end of NS2).  
 
p7-NS2-3-4A/sg: (Constructed by Eugene Agapov)  This genome expresses Npro  
and p7-NS2-3-4A from the BVDV IRES. The cloning strategy left 27 amino acids 
of C, 7 amino acids of Erns, and 48 amino acids of E2 between Npro and p7, and 
37 amino acids of NS4B after NS4A.  The downstream cistron, driven by the 
EMCV IRES, is identical to that of Npro-NS2/sg.  The XbaI/StuI fragment of Npro-
E2/sg (2) was replaced with the XbaI/DraI fragment of pNS2 Jiv 90-/sg (2).  
 
Ubi-NS2-3-4A/sg: This genome contains the BVDV IRES and 39 amino acids of 
Npro, followed by Ubi-NS2-3-4A. The cloning strategy left 37 amino acids of NS4B 
in the first cistron.  The downstream cistron, driven by the EMCV IRES, is 
identical to that of Npro-NS2/sg.  Nucleotides 1147 to 5120 of p7-NS2-3-4A/sg 
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were amplified by PCR using primers RU-2146 (5’-GTCCCCGCGGTGGCGATTC 
AGGGGGCCA-3’) and RU-2147 (5’-GCCAGTAACGCTCGGTACCC-3’).  A SacII 
site and ubiquitin (Ubi) cleavage consensus sequence (RGG) were engineered 
immediately upstream of NS2.  The PCR product was digested with SacII/MluI 
and ligated to the SphI/MluI fragment of p7-NS2-3-4A/sg and the SphI/SacII (Ubi) 
fragment of pSph-Npro-Ubi-PAC-EMCV IRES (2). 
 
p7-NS2-3-4A(Δ9-64)/sg: (Constructed by Eugene Agapov) This genome 
expresses Npro  and p7-NS2-3 from the BVDV IRES. The cloning strategy left 27 
amino acids of C, 7 amino acids of Erns, and 48 amino acids of E2 between Npro 
and p7.  Eight amino acids of NS4A remained in the first cistron followed by 5 
random amino acids and a stop codon. The downstream cistron, driven by the 
EMCV IRES, is identical to that of Npro-NS2/sg.  SpeI and MluI of p7-NS2-3-4A/sg 
were blunt ended and ligated. 
 
p7-NS2-3/sg:   The 4003 bp SphI/XmaI fragment of p7-NS2-3-4A/sg, the 524 bp 
XmaI/MluI fragment of p7-NS2-3(S1842A)/sg, and the 15843 bp MluI/SphI 
fragment of p7-NS2-3-4A/sg were ligated together.   
 
p7-NS2-3(S1842A)-4A/sg:  (Constructed by Eugene Agapov) This genome is 
identical to p7-NS2-3-4A/sg except for the S1842A change in NS3 in the first 
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cistron. The BsrGI/DrdI fragment of p7-NS2-3-4A/sg was replaced with the 
corresponding fragment derived from pTM3/BVDV/1598-3035(S1842A) 225. 
 
p7-NS2-3(S1842A)/sg:  This genome is identical to p7-NS2-3-(S1842A)-4A/sg 
except that the first cistron contains a stop codon immediately after NS3. 
Nucleotides 241 to 2668 and nt 2220 to 4765 of p7-NS2-3(S1842A)-4A/sg were 
amplified with primers RU-2170 (5’-ACGAGGGCATGCCCAAAGC-3) with RU-
2264 (5’-GTTGCCTACCATGAGCA-3’), and RU-2263 (5’-AAGAGGAGAGCAAA 
GGCT-3’) with RU-3286 (5’-CAGTACGCGTTTACCCTACAACCCGGTCACTT 
GCTTCA-3’), respectively.  A stop codon and MluI site were engineered into RU-
3286.  The 241-2668 product digested with SphI/PflMI and the 2220-4765 
fragment digested with PflMI/MluI were then ligated to p7-NS2-3 (S1842A)-4A/sg 
digested with SphI/MluI.  
 
Protein purification 
Expression and GST-fusion purification 
Amino-terminal GST fusion proteins were expressed in E. coli K12 
UT5600 (NEB, Ipswich, MA) or Rosetta cells (Novagen, San Diego, CA).  E. coli 
K12 UT5600 are deficient in the OmpT protease, Rosetta cells contain the 
pRARE plasmid encoding rare tRNAs and a chloramphenicol resistance gene.  
Expression and solubility were equivalent in either cell type.  Cells were grown in 
Luria-Bertani broth supplemented with appropriate antibiotics at 30°C with 
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agitation until an OD600 of 0.5 was reached.  Expression was then induced by 
addition of a final concentration of 0.5 mM isopropyl-β-D-thiogalactopyranoside 
(IPTG, Inalco, Milan, Italy).  Following induction, cells were grown at 18°C with 
agitation overnight.  Cells were pelleted at 4000 x g for 30 min at 4°C and pellets 
resuspended in 20 ml 0.5 M KCl, 20 mM Hepes [pH 7.4], 10% (v/v) glycerol per 
liter of bacterial cell culture.  Cells were lysed by three passages through a cold 
French pressure cell (Avestin, Ottawa, Canada) at >10 000 psi.  Unlysed and 
insoluble material were removed by centrifugation at 30 000 x g for 45 min at 
4°C.  Soluble material was loaded on a GSTrap fast protein liquid 
chromatography (FPLC) column (GE Healthcare, 5ml bed volume) equilibrated 
with buffer A1 (0.5 M KCl, 20 mM Hepes [pH 7.4]).  After washing with buffer B (1 
M KCl, 20 mM Hepes [pH 7.4]), fusion protein was eluted with 150 mM KCl, 100 
mM Tris [pH 8.0], 15 mM glutathione.  GST tag was removed by overnight 
treatment with Prescission protease (GE Healthcare, 0.5 mg per 1 mg protein) 
during dialysis against 4 L 100 mM KCl, 20 mM Hepes [pH 7.4] using snakeskin 
dialysis tubing (3000 molecular weight cut off (MWCO), Pierce, Rockford, IL).   
 
Non-denaturing purification 
After removal of GST, BVDV capsid 1-84 (C84) and BVDV capsid 1-87 
(C87) were further purified over SP sepharose or heparin FPLC columns (GE 
Healthcare) equilibrated with buffer A2 (100 mM KCl, 20 mM Hepes [pH 7.4]).  A 
linear salt gradient made from buffer A2 and buffer B (1M KCl, 20 mM Hepes [pH 
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7.4]) was used to elute the protein, with capsid-containing fractions eluting at 
approximately 470 mM KCl.  BVDV capsid 1-90 (C90) was further purified by 
binding to a heparin FPLC column (GE Healthcare) equilibrated with buffer A2.  A 
linear salt gradient made from buffer A2 and buffer B was used to elute the 
protein, with C87-containing fractions eluting at approximately 520 mM KCl.  
 
Denaturing purification 
After purification of the GST fusion proteins and cleavage of the GST as 
above, a final concentration of 1.0% acetonitrile/0.0325% trifluoroacetic acid 
(TFA) was added to denature the samples.  Denatured protein was loaded on a 
Source 5RPC ST 4.4/150 reverse phase high pressure liquid chromatography 
(HPLC) column (GE Healthcare, 2.5 ml bed volume) equilibrated with buffer A 
(2.0% acteonitrile/0.0625% TFA). A (0-50% B) linear acetonitrile gradient made 
from buffer A and buffer B (80% acetonitrile/ 0.05% TFA) was used to elute the 
protein, with capsid-containing fractions eluting at approximately 20% (C87) to 
24% (C90) acetonitrile.  Eluted fractions were lyophilized, resuspended in 6 M 
guanidine-HCl, 50 mM Hepes [pH 7.5], and refolded by dialysis into 100 mM KCl, 
20 mM Hepes [pH 7.4] using Slide-A-Lyzer mini dialysis units (3500 MWCO, 
Pierce). 
Protein was quantified by Abs280 using the extinction coefficients (ε) of 
2560 M-1cm-1 (C87) and 8250 M-1cm-1 (C90) and the equation Abs280/[(ε)(1cm)] 
=concentration (mol/L).  To concentrate protein or exchange buffer, Centricon 
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centifugal concentrators (3000 MWCO, Millipore, Billerica, MD) were spun 7500 x 
g at 4°C.  Concentrated protein was recovered by spinning the inverted Centricon 
at 2000 x g for 5 min.  Protein was stored in 100-500 mM KCl, 20 mM Hepes [pH 
7.4], 10% (v/v) glycerol or 100 mM KCl, 20 mM Hepes [pH 7.4] without glycerol 
for circular dichroism applications.  
Visualization of Coomasie Brilliant Blue stained SDS-PAGE was used to 
estimate sample purity at >90%.  For amino-terminal sequencing, protein was 
separated by SDS-PAGE and transferred to Sequiblot PVDF membrane (BioRad, 
Hercules, CA).  Membrane was stained 45 sec in 0.1% (w/v) Coomasie Brilliant 
Blue, 40% methanol, 10% acetic acid and destained in 50% methanol.  Dried 
membranes were sent to University of Texas Medical Branch protein chemistry 
core facility (Galveston, TX) for sequencing.  For mass spectrometry, liquid 
samples in 100 mM KCl, 20 mM Hepes [pH 7.5] were analyzed by the 
Rockefeller University proteomics resource center.   
 
Limited proteolysis assay.  0.2 µg endoprotease GluC (Roche, Mannheim, 
Germany) was used to digest 2 µg protein in 100 mM KCl, 20 mM Hepes [pH 7.4] 
at room temperature (RT).  After incubation, reactions were stopped by the 
addition of an equal volume of 2x SDS loading buffer with β-mercaptoethanol (β-
ME) and heating to 100°C for 5 min.  Samples were resolved by SDS-12% PAGE 
and visualized by silver staining.  
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Intrinsic fluorescence spectroscopy.  C90 protein (purified under non-
denaturing conditions) at 0.03 mg/ml in 100 mM KCl, 20 mM Hepes [pH 7.4] was 
analyzed using an Olis RSM1000F spectrofluorimeter.  For tyrosine spectra, the 
sample was excited at 280 nm and scanned from 300-430 nm wavelength in 1 
nm increments.  For tryptophan spectra, the sample was excited at 295 nm and 
scanned from 310-450 nm.  Spectra of buffer alone were subtracted from protein 
spectra.  
 
Circular dichroism spectroscopy.  Protein (purified under non-denaturing 
conditions) at 0.8-1.0 mg/ml (C87) or 0.3 mg/ml (C90) in 100 mM KCl, 20 mM 
Hepes [pH 7.4] was analyzed using AVIV 202 circular dichroism (CD) 
spectrometer.  Spectra were read from 250-200 nm wavelengths at 1 nm 
intervals.  Data plotted is the average of 2 scans with the spectrum of buffer 
alone subtracted.  CD readings were converted to molar ellipticity [Θ] using the 
equation:  
[Θ]= (Θobs*100* MW)/(c*l*n) 
Where ([Θ]) is in units of deg cm2/dmole, (Θobs) is the CD reading in degrees, 
(MW) is molar mass of the protein in g/mol, (c) is concentration of the protein in 
g/L, (l) is pathlength in cm, and (n) is the number of residues in the protein 
 
RNA homopolymer labeling and filter-binding assay.  RNA homopolymers 
(Dharmacon, Lafayette, CO) were deprotected according to manufacturers 
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instructions and resuspended in water.  20 pmol of each RNA homopolymer was 
end labeled in a 20 µl reaction volume containing 60 µCi 32P γ-ATP, 10 U T4 
polynucleotide kinase (PNK, NEB) and a final concentration of 1x PNK buffer 
(NEB) for 30 min at 37°C.  RNA was purified over a P30 spin column (Biorad), 
and resuspended to 1000 counts per minute (cpm)/ µl in 1x BB (200 mM KOAc, 
50 mM TrisOAc [pH 7.7], 5 mM Mg(OAc)2).  RNA was heated to 60°C for 5 min 
and slow cooled to RT immediately before use.  
For filter-binding assays, a nine point binding curve of two-fold dilutions of 
capsid protein was made in 1x BB from 0.05 µM to 5 µM concentration.  The final 
well contained no protein.  10 000 cpm of labeled homopolymer was added to 
each dilution of capsid protein (50 µl final volume) and incubated for 10 min at 
RT.  Filter-binding was conducted using a twelve well filter-binding apparatus 
(Millipore) and 0.45 µm nitrocellulose filters (Millipore).  45 µl of each reaction 
was spotted on a filter with vacuum source applied and immediately washed with 
5 ml 1x BB.  RNA alone, spotted on a filter without vacuum or washing, was a 
measure of total counts.  Filters were dried, submerged in ReadySafe scintillation 
cocktail, and counted for 12 sec using a scintillation counter.  Curves are fit using 
Prism graph pad non-linear regression for sigmoidal dose-response (variable 
slope) modified so that x=concentration of protein rather than log concentration.  
Dissociation constants were determined from the curve fit.      
For competition filter-binding assays, a twelve point binding curve of three-
fold dilutions of U oligomer was made in 1x BB from 50 nM to 3 mM of oligo. The 
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final well contained no competitor.  10 000 cpm of labeled U30 (approximately 5 
fmol) was added to each dilution of oligo U.  Finally, C90 was added to each well 
at a final concentration of 0.75 µM.  The final reaction volume was 50 µl. 
Reactions were incubated 10 min at RT, filtered, washed, dried and counted as 
above.  As oligo-Us are of different lengths, competitor is normalized to 
nucleotide concentration.  Curves are fit using one site competition (Prism Graph 
pad).  
 
Systematic evolution of ligands by exponential enrichment.  A DNA 
template for a 25-mer random RNA library was created by annealing 
oligonucleotide primers (5 nmol each) RU-4447 (5’-TCCCGCTCGTCGTCT [25N] 
CCGCATCGTCCTCCCT-3’) and RU-4448 (5’-GAAATTAATACGACTCACTATAG 
GGAGGACGATGCGG-3’) (87).  The mixed oligos, in a final concentration of 1x 
EcoPol buffer (NEB), were heated to 95°C for 5 min and cooled prior to the 
addition of 25 U DNA polymerase I (Klenow fragment, NEB) and 1 mM dNTPs.  
After 30 min at 37°C, the reaction was stopped by the addition of 25 mM EDTA 
and 2x RNA loading buffer (Ambion, Austin, TX).  The blunt ended template was 
purified from a 20% native acrylamide gel, run in 1x TBE (90 mM Tris, 90 mM 
boric acid, 2 mM EDTA).  Bands were visualized by UV shadowing, and the 
excised DNA was eluted from the gel by shearing through a 1 ml syringe, 
extraction at 37°C for 30 min in elution buffer (1 M NaOAc [pH 5.2], 1 mM EDTA), 
and subsequent clarification through a 0.22 µm tube filter (Corning, Lowell, MA).  
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DNA was precipitated with 2 volumes ethanol/isopropanol, centrifuged at 16 000 
x g for 20 min, and resuspended in 100 µl water; template was quantified by 
absorbance at 260 nm. 
For RNA synthesis, 500 pmol of template was transcribed in a 1 ml 
reaction containing final concentrations of 1x T7 transcription buffer (Promega), 2 
mM NTPs, 10 mM DTT, 2000 U T7 RNA polymerase (Ambion, Austin, TX), 800 
U RNAsin (Promega, Madison, WI), and 200 µCi 32P α-UTP.  Reactions were 
incubated at 37°C for 4-6 h, and for an additional 15 min with 60 U DNAse I 
(Invitrogen).  The reaction was stopped by addition of 50 mM EDTA and RNA 
was precipitated with 200 µg glycogen, 300 mM NaOAc, 5 volumes ethanol, 
followed by pelleting at 16 000 x g for 20 min.  RNA was resuspended in 1x 
urea/EDTA loading buffer (4.5 M urea, 0.5 mM EDTA, 0.025% (w/v) bromophenol 
blue, 0.025% (w/v) xylene cyanol in 1x TBE) and heated to 95°C for 5 min before 
loading on a 15% acrylamide/7 M urea denaturing gel.  RNA was visualized by 
autoradiography and the band excised and purified as for the DNA template.  The 
affinity of C87 for the RNA pool was measured by filter-binding assay as 
described above. 
For selection, protein, at a concentration found to bind 5% of the library, 
was incubated with a 10 to 50-fold molar excess of RNA in 1x BB for 10 min at 
RT.  Unbound RNA was removed by filtering through nitrocellulose (Millipore) and 
washing with 2 ml 1x BB.  Filters were dried and counted without scintillation 
cocktail using Cherenkov radiation.  Background binding of RNA was analyzed in 
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parallel to ensure nitrocellulose-specific sequences were not evolved.  Bound 
RNA was removed from the filter by extraction in 200 µl 7 M urea, 400 µl phenol, 
130 µl chloroform.  After incubation at RT for 45 min with shaking, 130 µl water 
was added, samples were centrifuged at 16 000 x g for 5 min, and the aqueous 
phase was removed and added to 1 M NaOAc, 40 µg glycogen, 7 volumes 
ethanol/isopropanol.  Precipitated RNA was used for reverse transcription (RT) 
and PCR.  
For RT-PCR, extracted RNA was incubated with a final concentration of 
0.5 mM dNTPs and 50 pmol RU-4440 (5’-TCCCGCTCGTCGTCTG-3’) for 3 min 
at 70°C.  After 2 min on ice final concentrations of 1x first strand buffer 
(Invitrogen), 10 mM DTT, 20 U RNAsin (Promega), and 100 U SuperScript II 
reverse transcriptase (Invitrogen) were added and incubated at 42°C for 1.5 h, 
followed by 72°C for 7 min.  10 U RNaseH (Epicenter, Madison, WI) and 1000 U 
RNaseT1 (Ambion) were added and incubated at 37°C for 20 min.  The RT 
reaction was then PCR amplified with 1x thermopol buffer (NEB), 0.2 mM dNTPs, 
50 pmol RU-4440, 50 pmole RU-4448, and 50 U Taq DNA polymerase 
(Invitrogen) in a final reaction volume of 500 µ l.  PCR products were precipitated 
with 50 µg glycogen, 300 mM NaOAc, 2.5 volumes ethanol, pelleted at 16 000 x 
g for 20 min, resuspended in 100 µ l water and used as a template for next round 
of transcription.     
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Creation of monoclonal and polyclonal antibodies.  The immunogen for both 
monoclonal and polyclonal antibodies was NADL capsid protein C84 purified 
under non-denaturing conditions.  The GST tag was removed during the 
purification, as outlined above.  
 
Monoclonal anti-BVDV capsid antibodies 
 Five mice were immunized five times with 120 µg C84 (monoclonal 
antibody core facility, Memorial Sloan Kettering, NY).  Hybridomas were 
screened by enzyme-linked immunosorbent assay (ELISA) against recombinant 
C84.  The first mouse selected for fusion did not result in any capsid-specific 
antibodies.  The second mouse fused produced two antibody positive clones, 
4F8 and 5E10.  These antibodies are both isotype IgG1, κ light chain.  
Hybridoma supernatants of 4F8 and 5E10 worked in Western blot (1:500), 5E10 
in immunoprecipitation, and 5E10 for immunofluorescence (1:500). 
 
Polyclonal anti-BVDV capsid antibodies 
Two rabbits (animals 886 and 887) were immunized with 100 µg C84 
followed by three boosts with 50 µg protein (Cocalico, Reamstown, PA).  Sera 
were screened in Western blot against NADL-infected cells lysates.  Production 
bleeds from 10-Oct-02 to 22-Jul-03 (886) could be used at 1:5000 to 1:20 000; 
26-Nov-02 to 27-May-03 (887) at 1:5000. Sera 10-Dec-02 and 24-Dec-02 (886) 





Plasmids were linearized by digestion with XhoI for 3 h at 37°C and templates 
were purified over Minelute column (Qiagen, Valencia, CA).  0.6 µg was 
transcribed in a 10 µl reaction using the SP6 mMessage mMachine kit containing 
cap analog (Ambion).  Reactions were incubated for 3 h at 37°C, with 
subsequent treatment with 3 U DNAseI (Ambion) for 15 min at 37°C.   RNA was 
purified over RNeasy column (Qiagen), quantified by absorbance at 260 nm, and 
its integrity verified by 0.8% agarose gel electrophoresis.  
 
HCV 
Plasmids were linearized by digestion with XbaI for 3 h at 37°C, templates were 
purified over Minelute column (Qiagen) and 1 µg DNA was transcribed in a 10 µl 
reaction using the T7 Megascript kit (Ambion).  Reactions were incubated at 
37°C for 3 h followed by 15 min digestion with 3 U DNAseI (Ambion).  RNA was 
cleaned up by RNeasy kit (Qiagen) with an additional on-column DNAse 
treatment for those samples that would subsequently be analyzed by quantitative 
reverse transcription-PCR (qRT-PCR).  RNA was quantified by absorbance at 




Plasmids were linearized by digestion with SbfI for 2 h at 37°C and blunt-ended 
by addition of 2 U of DNA polymerase I (Klenow fragment, NEB) and 1.2 U of T4 
DNA polymerase (NEB), followed by 0.8 µM dNTPs.  Templates were purified by 
extraction once with phenol, twice with chloroform, and precipitated with ethanol 
and 3 M NaOAc.  Transcription of 1 µg template was performed in a 20 µl 
reaction using the T7 Megascript kit (Ambion).  Reactions were incubated for 2 h 
at 37°C after which RNA was purified using the RNeasy kit (Qiagen).  RNA was 
quantified by absorbance at 260 nm, and its integrity verified by 0.8% agarose 
gel electrophoresis. 
 
RNA transfection and growth curves.   
Sindbis 
For electroporation, BHK 21 cells were trypsinized, washed twice with ice-cold 
RNase-free phosphate-buffered saline (AccuGene PBS; BioWhittaker, Rockland, 
Maine), and resuspended at 2 x 107 cells/ml in PBS.  3 µg of each RNA to be 
electroporated was mixed with 0.4 ml of cell suspension and immediately pulsed 
with an ElectroSquare Porator ECM 830 (BTX, Holliston, MA) (960 V, 99 µsec, 
five pulses).  Electroporated cells were diluted in 30 ml MEM/7.5% FBS and 
plated into 24 well and P100 tissue culture dishes.   
 At 6 h post-electroporation cells in 24 well plates were washed with 
Dulbecco’s PBS (DPBS) and lysed with cell culture lysis buffer (Promega) for 
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assay of firefly luciferase activity.  At 24 h post-transfection, cell culture 
supernatants from the P100 dishes were completely removed, clarified with a 
0.22 µm filter, aliquoted, and frozen at -80°C for analysis of infectivity; fresh 
DMEM/10 mM nonessential amino acids/10% FBS was then added to the cells.  
Infectivity was assayed by infection of approximately 5 x 104 cells with 200 µl 
clarified supernatant and incubation for 1.5 h, after which inoculum was removed 
and 600 µl fresh medium was added.  After a total of 4 h of infection, cells were 
lysed with cell culture lysis buffer (Promega) and analyzed for luciferase activity.  
Each infection was done in triplicate. 
 
HCV 
Huh-7.5 cells were trypsinized, washed twice with ice-cold RNase-free PBS 
(AccuGene), and resuspended at 1.5 x 107 cells/ml in PBS.  2 µg of each RNA to 
be electroporated was mixed with 0.4 ml of cell suspension and immediately 
pulsed with an ElectroSquare Porator ECM 830 (BTX) (820 V, 99 µsec, five 
pulses). Electroporated cells were diluted in 30 ml of DMEM/10 mM nonessential 
amino acids/10% FBS and plated into 24 well and P100 tissue culture dishes.   
 At 8, 24, 48 and 72 h post-electroporation cells in 24 well plates were 
washed with DPBS and lysed with Renilla lysis buffer (Promega) or with RLT 
buffer (Qiagen) containing 0.14 M β-ME (RLT/β-ME) for assay of replication by 
luciferase activity or qRT-PCR, respectively.  At the same time points, cell culture 
supernatants from the P100 dishes were completely removed, clarified with a 
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0.22 µm filter, aliquoted, and frozen at -80°C for analysis of infectivity; fresh 
DMEM/10 mM nonessential amino acids/10% FBS was then added to the cells.  
For reporter viruses, infectivity was assayed by infection of naïve cells with 600 µl 
of clarified supernatant and incubation for 48 h, with subsequent lysis in Renilla 
lysis buffer (Promega) and analysis of luciferase activity.  Each infection was 
done in triplicate. 
 
BVDV 
MDBK cells were trypsinized, washed three times with ice cold RNase-free PBS 
(AccuGene), and resuspended at 2 x 107 cells/ml in PBS.  5 µg of each RNA to 
be electroporated was mixed with 0.4 ml of the cell suspension and immediately 
pulsed with an ElectroSquare Porator ECM 830 (BTX) (900 V, 99 µs, 5 pulses).  
Electroporated cells were diluted in 10 ml DMEM/10% HS and plated in 35 mm or 
P100 tissue culture dishes.   
 
Western blot.   
Sindbis 
Cells were lysed at 6 h post-electroporation or 4 h post-infection with cell culture 
lysis buffer (Promega).  Lysates were separated on SDS-12% PAGE.  After 
transfer to nitrocellulose membrane, blots were blocked for 1 h with 5% 
milk/TBST (0.02 M Tris-Cl [pH 7.4], 0.2 M NaCl, 0.1% (v/v) Tween-20).  For 
Sindbis capsid detection, anti-C polyclonal antibody (169), was diluted 1:5000 in 
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TBST.  After overnight incubation at 4°C, and extensive washing with TBST, 
goat-anti-rabbit immunoglobulin-horseradish peroxidase secondary antibody 
(Pierce) was added at 1:5000 dilution in 5% milk/TBST for 30 min at RT.  After 
additional washing, blots were developed with SuperSignal West Femto 
chemiluminescent substrate (Pierce). 
 
HCV 
Cells were lysed at 48 h post-electroporation with Renilla lysis buffer (Promega).  
Lysates were separated on SDS-12% PAGE for analysis of core and β-actin, and 
on SDS-10% PAGE for analysis of NS5A.  After transfer to nitrocellulose 
membrane, blots were blocked for 1 h with 5% milk/TBST.  For core detection, 
monoclonal antibody (mAb) HCM-071-5 (Austral biologicals, San Ramon, CA), 
which recognizes amino acids 10-53, was diluted 1:750 to 1:1000 in TBST.  For 
NS5A detection mAb 9E10 (115) was diluted 1:100 in TBST. After overnight 
incubation at 4°C, and extensive washing with TBST, rabbit-anti-mouse 
immunoglobulin-horseradish peroxidase secondary antibody (Pierce) was added 
at 1:5000 dilution in 5% milk/TBST for 30 min at RT.  After additional washing, 





For detection of NS3, cells were lysed with passive lysis buffer (Promega) at 24 h 
post-electroporation and clarified by centrifugation at 18 000 x g for 30 seconds.  
Lysates were separated by SDS-10% PAGE and transferred to a nitrocellulose 
membrane and blots were blocked for 1 h with 5% milk/TBST.  Polyclonal anti-
NS3 antiserum (G40) was diluted 1:500 in 3% BSA and incubated for 1 h.   After 
washing with TBST, the secondary antibody (goat-anti-rabbit-horse radish 
peroxidase (HRP), Pierce) was added at 1:10 000 dilution in 5% milk/TBST and 
incubated for 30 min at RT.  For capsid detection, cells were lysed 6 h post-
electroporation or 24 h post-infection with cell culture lysis buffer (Promega) and 
lysates were separated on SDS-12% PAGE.  After transfer to nitrocellulose 
membrane, blots were blocked for 1 h with 5% milk/TBST, and incubated 
overnight at 4C with polyclonal anti-capsid antiserum 886 10-Oct-02 diluted 
1:5000 in 5% milk/TBST.  Goat-anti-rabbit immunoglobulin-horseradish 
peroxidase secondary antibody (Pierce) was added at 1:5000 dilution in 5% 
milk/TBST for 30 min at RT.  After washing, blots were developed with 
SuperSignal West Femto chemiluminescent substrate (Pierce). 
For detection of β-actin, the primary antibody (mouse-anti-β-actin, Sigma, 
St Louis, MO) was diluted 1:5000 in 5% milk/TBST and the secondary antibody 
(rabbit-anti-mouse-HRP, Pierce) was diluted 1:2500 in 5% milk/TBST.  After 
removal of the secondary antibody by washing with TBST, blots were developed 
with SuperSignal West Pico or WestFemto Chemiluminescent substrate (Pierce).  
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HCV RNA extraction and qRT-PCR.  For analysis of HCV RNA replication, total 
RNA was extracted from cells lysed with RLT/β-ME (Qiagen) and homogenized 
by centrifugation through a QiaShredder column (Qiagen) for 2 min at 14 000 x g.  
RNA was isolated by RNeasy kit (Qiagen) and quantified by absorbance at 260 
nm.  50 ng of total cellular RNA was used per qRT-PCR.  For analysis of 
released viral genomes, RNA was isolated from 1 ml of cell culture supernatant, 
harvested at 48 h post-electroporation, using the QiaAmp UltraSens kit (Qiagen).  
2 µl of isolated RNA was used per qRT-PCR reaction.   
qRT-PCR reactions were performed using the Light Cycler amplification kit 
(Roche, Basel, Switzerland) with primers directed against the viral 5’UTR.  20 µl 
reactions were assembled according to the manufacturers instructions.  
Quantitative RT-PCR amplification and analysis were performed using the 
LightCycler 480 (Roche) and associated software.   
 
HCV Core ELISA.  HCV antigen ELISA (Ortho Clinical Diagnostics, Raritan, NJ) 
was performed according to the manufacturer’s instructions.  Briefly, cell culture 
supernatants harvested at 48 h post-electroporation were diluted 1:10 (wild-type 
J6/JFH(p7Rluc2A)) or undiluted (mutants) and applied to plates coated with a 
mixture of anti-core mouse mAbs.  Antigen was detected by addition of a second 
mAb cocktail, conjugated to HRP.  Use of multiple mAbs with non-overlapping 
epitopes ensured detection of all the core mutants.  After washing, wells were 
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developed by addition of substrate and subsequent stop solution; absorbance at 
490 nm was measured.  Core was quantified using Softmax software and 
comparison to a standard curve assayed in parallel. 
 
RT-PCR.  For analysis of HCV revertants and verification of infectious viruses, 
total cellular RNA was isolated from cells 48 h post-infection by RNeasy as 
described above.  Approximately 0.2 ng of RNA was converted to first-strand 
DNA using SuperScript III first-strand synthesis kit (Invitrogen) and primers RU-
5716 (5’-CTGCGGAACCGGTGAGTACAC-3’), RU-5927 (5’-CAAGGTCTCCCA 
CTTTCAG-3’), RU-5999 (5’-GTGTACCTAGTGTGTGCCGCTCTACC-3’), and 
RU-6000 (5’-ATGCCGCTAATGAAGTTCCAC-3’).  After digestion with 1 U of 
RNaseH for 20 min at 37°C, one quarter of the RT reaction was PCR amplified 
using appropriate primers.  The PCR products were gel purified using GFX 
columns (GE Healthcare) and used directly for sequencing. 
 
HCV titer by limiting dilution.  Clarified cell culture supernatants harvested at 
various time points post-electroporation were serially diluted and 50 µl of each 
dilution used to infect approximately 3 x 103 cells.  At 72 h post-infection, cells 
were fixed and infected cells detected by immunohistostaining for NS5A.  Fifty 
percent tissue culture infectious dose (TCID50) was calculated as previously 
reported (115).   
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HCV intracellular infectivity assay. Cells were collected at 72 h post-
electroporation by trypsinization and pelleting at 500 x g for 3 min.  Pellets were 
washed and resuspended in 500 µl DMEM/1x non-essential amino acids/10% 
FBS.  Cells were lysed by four freeze-thaw cycles, and debris pelleted by twice 
centrifuging at 1500 x g for 5 min.  The supernatant was collected and used for 
infection of naïve cells in the presence of 10 µg/µl anti-CD81 mAb (JS81, 
Pharmingen, San Diego, CA) or an isotype control (anti-mouse IgG1, 
Pharmingen).  After 24 h of infection, the media was removed and replaced, and 
after an additional 24 h, cells were lysed in RLT/β-ME and total cellular RNA 
harvested for qRT-PCR analysis as above. 
 
Immunohistochemistry.  For immunohistochemical detection of HCV NS5A 
cells were fixed with 100% methanol at 48 h post-electroporation, blocked for 1 h 
with PBS, 0.2% (w/v) milk, 1% BSA, 0.1% saponin, and subsequently incubated 
for 5 min with 3% hydrogen peroxide.  After washing with PBS and PBSS (PBS 
with 0.1% saponin), cells were incubated for 1 h at RT with 1:200 dilution of anti-
NS5A mAb (9E10, ref 115).  The secondary antibody, ImmunPress goat-anti-
mouse peroxidase (Vector, Burlingame, CA), was diluted 1:10 and incubated for 
30 min at RT.  After washing, staining was developed with DAB substrate 





Approximately 3x105 cells were plated on glass bottom 35 mm dishes (MatTek, 
Ashland, MA) at 72 h post-electroporation.  After 24 h, cells were fixed with 4% 
paraformaldehyde in PBS for 30 min at RT.  Fixed cells were incubated with 
PBST (PBS, 0.1% Triton X-100) for 30 min RT, followed by washing with PBS.  
Cells were blocked with PBSF (PBS, 1% FBS) for 1 h RT and stained for core.  
Primary anti-core mAb HCM-071-5 (Austral biologicals) diluted 1:1000 in PBSF 
was incubated at 4°C overnight.  After washing with PBSF, secondary antibody 
Alexa 488-goat-anti-mouse IgG (Invitrogen) diluted 1:1000 in PBSF was 
incubated for 2 h at RT.  Following washing with PBSF, cells were stained for 
lipid droplets.  Cells were rinsed with 60% isopropanol in H2O followed by 
incubation with 0.6% Oil red O in 60% isopropanol for 2 min at RT.  Oil red O 
(Sigma) was diluted from a stock solution of 1% Oil red O in isopropanol and 
filtered through a 0.45 µm filter immediately before use.  Cells were washed with 
60% isopropanol, followed by PBS and H2O.  Cells were overlaid with PBS and 
viewed on a Zeiss LSM 510 confocal microscope; colocalization was analyzed 
using the associated software. 
 
BVDV 
Cells plated on culture slides (Becton Dickinson, Franklin Lakes, NJ) were 
washed with DPBS (Invitrogen) and fixed for 20 min with 50% methanol/50% 
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acetone.  After washing twice, anti-NS3 antibody (mAb 184, ref 47) was added at 
a 1:2000 dilution in PBSG (PBS, 5% goat serum).  Cells were incubated for 1 h at 
RT and then washed twice with PBSG.  The secondary antibody (goat-anti-
mouse IgG-Alexa 594, Molecular Probes, Eugene, OR) was added at a 1:2000 
dilution in PBSG and cells were incubated for 20 min at 4°C.  Hoescht 33342 (1 
µg/ml) was added and cells were incubated an additional 10 min at 4 °C.  Cells 
were washed 3 times with PBSG and coverslips were mounted.  Slides were 
viewed using a Nikon Eclipse TE 300 microscope. 
 
Heat inactivation of HCV virions.  Clarified cell culture supernatants were 
incubated at 47°C for 30 min to 18 h.  200 µl heat-treated or untreated 
supernatants was used to infect approximately 1 x 105 cells in a 24 well plate.  
After 2 h, 400 µl media was added to the inoculum and cells were incubated an 
additional 48 h before lysis with RLT/β-ME and purification of total RNA for qRT-
PCR.   
 
Flow cytometry (FACS).  Infected or electroporated cells in 35 mm dishes were 
trypsinized, washed twice with DPBS, and fixed with 0.5% paraformaldehyde in 
PBS for 20 min at RT.  Cells were blocked and permeabilized with PBS, 5% (v/v) 
GS, 0.1% (w/v) sodium azide, 0.1% (w/v) saponin for 20 minutes at RT.  Primary 
anti-BVDV NS3 antibody (mAb 184) was added at 1:2000 dilution in SB (PBS, 
0.5% (w/v) BSA, 0.1% (w/v) sodium azide, 0.1% (w/v) saponin).  Cells were 
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incubated for 1 h at RT and then washed twice with SB.  Secondary antibody 
(goat-anti-mouse IgG Alexa 488, Molecular Probes) was added at 1:1000 dilution 
in SB and cells were incubated for 30 min at RT.   Cells were washed twice with 
SB and analyzed by flow cytometry on a FACSCalibur (Beckton Dickinson), 
counting 1 x 104 cells for replication assay and 1 x 105 cells for infectivity assay.  
Titers of supernatants were calculated from the average percentage of NS3-
positive cells.  Infected wells were estimated to contain 1x 106   cells; this number 
was calculated by seeding cells under the same conditions as the assay and 
counting 24 wells in two independent platings.  Since the viruses are incapable of 
cell-to-cell spread, FACS counts were expected to reflect the number of cells 
infected by the initial inoculum. 
 
Amino acid alignments.  HCV protein alignments were created using the HCV 
sequence database amino acid alignment tool (http://hcv.lanl.gov/content/hcv-




Chapter 3: BVDV capsid is a natively unfolded protein that binds RNA 
 
Introduction 
 All viruses must package a nucleic acid genome into a compact, stable, 
and dissociable structure for efficient transport to the next host cell.  For the 
enveloped positive-strand RNA viruses, a nucleic acid molecule several thousand 
bases in length must be packaged into a particle of less than 100 nm in diameter.  
The viral capsid proteins responsible for this genomic RNA packaging vary in 
sequence and in structure.  Unlike the capsid proteins of DNA and non-
enveloped RNA viruses, which commonly adopt a conserved eight-stranded β-
barrel motif, enveloped RNA virus capsid proteins are structurally diverse, 
suggesting distinct evolutionary lineages (48).  These proteins resemble folds as 
disparate as chymotrypsin (Togavirus, ref 36, 37), a translation initiation factor 
domain (Flavivirus, ref 124, 50), and the HLA peptide recognition domain 
(Arterivirus and Coronavirus, ref 48, 86, 229) (Fig 3-1).  
 Within the Flaviviridae family, capsid protein structures have been 
determined for DENV and WNV, both members of the Flavivirus genus (Fig 3-1, 
ref 124, 50).  These proteins are helix-rich and associated as dimers and 
tetramers.  The anti-parallel helix interface of the WNV capsid protein tetramer 
has been compared to both an archeal transcription factor and a HEAT repeat 
domain similar to that found in eIF4G (50).  Neither HCV core protein, nor a 


















Fig 3-1.  Capsid proteins of enveloped positive-strand RNA viruses have 
disordered regions.  Capsid protein structures of (A) Semliki Forest virus, a 
Togavirus related to Sindbis virus (37, 229), (B) Porcine respiratory and 
reproductive syndrome virus, an Arterivirus (48), and (C) dengue virus and West 
Nile virus, Flaviviruses (50, 124).  (D) HCV and BVDV capsid protein structures 
are not known.  Blue bars represent predicted structured domains, white line 
represents SPP cleavage site.  Grey lines indicate unresolved (A-C) or predicted 
disordered residues (D).
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Secondary structure predictions, spectral analyses, and analytical 
ultracentrifugation have indicated that, similar to the classical Flaviviruses, the 
HCV core protein is dimeric and rich in helices (25, 24).   The BVDV capsid 
protein is similar in size to the classical Flavivirus capsids, but, unlike these 
sequences, is predicted to contain minimal helical content.  In fact, its proposed 
lack of secondary structure and low sequence complexity fit better with the 
hypothesis that BVDV capsid protein is predominantly disordered.  
Unstructured regions are not uncommon in viral capsid proteins.  For 
enveloped positive-sense RNA viruses, disordered sequences containing a high 
concentration of positively charged residues are ubiquitously found in the capsid 
protein amino-terminal domains (Fig 3-1).  These disordered amino-termini range 
in length from 19 to 118 amino acids and are not resolved in the crystal 
structures.  Both DENV and WNV capsid proteins contain flexible, basic amino-
terminal regions of approximately 20 amino acids (124, 50).  HCV core protein 
has a predicted unstructured domain encompassing the highly basic 117 to 124 
amino-terminal residues (Fig 3-1).  The flexibility of this region has been 
supported by circular dichroism and intrinsic fluorescence spectra measurements 
(25, 106).   
 The function of the disordered amino-terminal extensions is presumed to 
be the nonspecific binding and condensation of the RNA genome within the 
virion.  This process is best understood for the Alphaviruses, a well-characterized 
group of enveloped positive-strand RNA viruses in the Togaviridae family.  
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Sindbis virus, the prototype Alphavirus, encodes three major structural proteins, 
capsid (C), and envelope proteins E1 and E2, translated as a NH2-C-E3-E2-6K-
E1-COOH polyprotein from a subgenomic RNA produced subsequent to RNA 
replication.  The Sindbis virus capsid protein is 264 amino acids in length, with 
the carboxy-terminal 150 residues forming a chymotrypsin-like serine protease 
that mediates a single autoproteolytic cleavage (reviewed in 63).  This domain 
also functions later in assembly, mediating an essential interaction with the 
cytoplasmic tail of E2 via a hydrophobic pocket located close to the protease 
active-site.  The amino-terminus of the capsid protein is rich in lysine, arginine, 
and proline residues, which contribute to both specific and nonspecific 
associations with RNA (64, 117).  The amino-terminus also contains sequences 
required for nucleic acid-dependent dimerization (204), and a putative leucine 
zipper that has been shown to stabilize these dimers (157, 81).  Cryo-EM image 
reconstructions, combined with fitting of individual protein crystal structures have 
provided a view of capsid protein architecture within the intact Alphavirus particle 
(231, 147).  Beneath the virion envelope, the nucleocapsid is a well-ordered T=4 
icosahedral shell, with the capsid protease domains forming pentameric and 
hexameric protrusions from the RNA-containing interior.  The flexible amino-
terminal residues of the capsid protein extend from the ordered protease 
domains into the nucleocapsid core, forming a mixed protein-RNA region that 
does not have a well-resolved structure  (35, 231). These studies demonstrated 
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that the disordered amino-terminus of Sindbis virus capsid protein is involved in 
nonspecifically binding and condensing the genomic RNA.   
The Pestivirus capsid protein is unique among the enveloped RNA viruses 
in that it appears to contain only the disordered region and not the prominent 
structural domain seen in related viral proteins.  This predicted paucity of 
structure is at once distinct to the Pestivirus capsid and relevant in understanding 
important related viruses such as HCV.  We therefore investigated how this 
sequence might function mechanistically. 
 
Results 
Expression and purification of recombinant BVDV capsid protein  
 We cloned and expressed two versions of BVDV capsid protein 
encompassing the amino-terminal 87 (C87) or 90 (C90) residues fused to 
glutathione-S-transferase (GST, Fig 3-2A).  We hypothesized that deletion of the 
majority of the capsid hydrophobic tail would facilitate purification and result in 
proteins related (C87) or identical to (C90) the mature, virion-associated capsid 
(78).  C87 and C90 were initially purified under non-denaturing conditions using a 
two-step scheme (Fig 3-2B, top).   GST-capsid fusion proteins were bound to a 
GSTrap column in 0.5 M KCl, 20 mM Hepes [pH 7.4].  After washing with high 
salt to remove nonspecifically bound proteins and nucleic acid, the fusion 
proteins were eluted with glutathione, and the GST moiety removed by 


































































































and  dialyzed 
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Fig 3-2.  Purification  of recombinant  BVDV capsid  protein.  (A) Schematics
of  BVDV capsid  protein  and  GST-fusion  proteins.  GST,  white,  BVDV capsid, 
grey.  (B) Non-denaturing and denaturing purification schemes  for C87 and C90.  
Shading  indicates use of  column. (C) GSTrap purification of GST-C87, left, and 
GST-C90,  right.  GST  cleaved overnight  at 4oC with PreScission protease, final 
lanes.  Samples run on SDS-12%PAGE and stained with Coomasie brilliant blue.
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mM Hepes [pH 7.4] (Fig 3-2C).  C87 was further purified over an SP sepharose 
column and eluted within a salt gradient at approximately 470 mM KCl.  C90 was 
further purified by binding to a heparin column, eluting at approximately 520 mM 
KCl.  C87 yields were approximately 3 mg/L bacterial culture whereas C90 yields 
were between 0.05-0.1 mg/L.  
Since C90 could not be purified to satisfactory yields under non-denaturing 
conditions, a denaturing purification scheme was devised (Fig 3-2B, bottom).  
After purification of GST-C87 or GST-C90 fusion proteins and removal of GST as 
above, a final concentration of 1% acetonitrile/0.0325% trifluoroacetic acid (TFA) 
was added.  Denatured protein was loaded on a Source 5RPC ST 4.4/150 
reverse phase column and eluted with an acetonitrile gradient.  Eluted proteins 
were lyophilized, resuspended in 6 M guanidine HCl, 50 mM Hepes [pH 7.5], and 
refolded by dialysis into 100 mM KCl, 20 mM Hepes [pH 7.4].  Yields of C87 
purified under denaturing condition were 0.5 mg/L bacterial culture whereas C90 
yields were again 0.1 mg/L.  The denaturing protocol had the advantage of 
destroying a co-purifying phosphatase activity, allowing capsid proteins to be 
assayed for binding to end-labeled nucleic acids without additional purification 
steps (data not shown).  The identities of recombinant proteins produced by 
denaturing and non-denaturing methods were verified by mass spectrometry and 
amino-terminal sequencing. 
 These results showed that recombinant BVDV capsid protein could be 
expressed in and purified from bacteria.  The deletion of three residues in C87 
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drastically increased yields over C90, possibly because of the hydrophobic 
nature of these amino acids.  
 
BVDV capsid is a natively unfolded protein 
 Recently, a growing number of proteins from a wide variety of sources 
have been found to lack distinct secondary or tertiary structure and have been 
termed natively unfolded (reviewed in 208, 53, 212).  These proteins share 
similar characteristics including low primary sequence complexity, high 
susceptibility to proteases, anomalous migration on SDS-PAGE, and lack of 
secondary structure by spectral methods (208).   Since BVDV capsid is a highly 
basic protein, poor in hydrophobic residues, we decided to test the hypothesis 
that BVDV capsid possesses other characteristics of a natively unfolded protein.  
Proteins purified under non-denaturing conditions were tested in various assays 
for characteristics of intrinsically disordered proteins.   
 
Secondary structure predictions 
 Secondary structure prediction algorithms were used to estimate the 
helical nature of the full-length BVDV capsid protein (residues 1-102).  Only the 
carboxy-terminal region was predicted with high confidence to contain helix-
forming residues (Fig 3-3A, ref 175).  This is in keeping with the function of this 
region as a signal sequence for Erns.  The prediction of natively disordered 
regions (PONDR) algorithm was used to determine if BVDV capsid was likely to 




















































































Fig 3-3.  BVDV capsid is natively unfolded.  (A) BVDV capsid protein 
sequence and  secondary  structure  predictions.  Predicted disordered 
regions, bold, and  proposed helices, underlined.  SPP cleavage site 
designated by an arrow. (B) Limited proteolysis of C87, left, and C90, right, 
with endoprotease GluC.  Incubation times at RT are indicated (min).  
(C) Tyrosine intrinsic fluorescence spectrum of C90.  Dotted line indicates 
340 nm.  Circular dichroism spectra of C87 (D) and C90 (E). 
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sequence complexity and paucity of hydrophobic residues as indicators of 
disorder.  Analysis of the BVDV capsid protein indicated a high propensity for an 
unfolded structure (Fig 3-3A).  These results predicted that BVDV capsid consists 




 Natively unfolded proteins have a large proportion of solvent-exposed 
residues and are therefore highly susceptible to proteolysis.  Treatment of C87 or 
C90 with endoprotease GluC resulted in almost completely digestion within one 
minute when the capsid protein was present in ten-fold excess (Fig 3-3B).  
Similar results were seen with trypsin and chymotrypsin; for all three enzymes 
proteolysis of C87 was complete within one hour even when capsid protein was 
in 300-fold excess (data not shown).  These results suggested that the majority of 
capsid residues are accessible to proteases rather than protected within the 
hydrophobic core of the protein.  
 
Intrinsic fluorescence spectroscopy 
 C90 contains two tyrosines, at positions 51 and 69, and one tryptophan, at 
position 89.  Intrinsic fluorescence of these residues can be used to determine 
their environment since the wavelength of emission correlates with the degree of 
solvent exposure.   Emission maxima for both tyrosine (Fig 3-3C) and tryptophan 
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spectra (data not shown) were at approximately 360 nm wavelength.   Since an 
emission maximum greater than 340 nm indicates a high degree of solvent 
exposure, these results suggested that the capsid protein lacked significant 
globular structure. 
 
Circular dichroism spectroscopy 
 Far UV circular dichroism (CD) indicates the presence of secondary 
structural elements in a protein by measuring the interaction of the protein with 
elliptically polarized light (reviewed in 94).  Alpha helices, β-sheets, and 
disordered random coil sequences produce distinctive spectra, which can be 
deconvoluted to indicate the proportion of each structural element in the protein.  
Analysis of C87 by circular dichroism indicated a minimum at approximately 195 
nm, indicating a large proportion of random coil (Fig 3-3D).  Minima at 208 nm or 
222 nm, indicative of α-helical and β-sheet secondary structures, were not 
observed.  C90 produced similar results, although the lower protein concentration 
made the data less reliable (Fig 3-3E).  Taken together, these results suggest the 
presence of large regions of disorder within the BVDV capsid protein.   
 
BVDV capsid binds RNA with low affinity and low specificity 
 The extremely basic nature of the BVDV capsid protein, as well as its 
suspected close proximity to the viral genome within the virion led us to 
hypothesize that capsid may bind to RNA.   
 65 
Filter-binding assay 
 In order to test C87 and C90 for RNA binding activity, we used a 
quantitative filter-binding assay.  Radiolabeled RNA homo-oligomers of 
adenosine (A), cytidine (C), guanosine (G), and uridine (U) (30 nt in length) were 
added at constant concentration to a dilution series of protein.  Protein purified 
under denaturing conditions was used in this assay in order to eliminate a 
bacterial phosphatase that co-purified under native conditions (data not shown).  
RNA-protein mixtures were applied to nitrocellulose filters under vacuum, 
washed, and RNA retained on the filter was quantified.  Whereas unbound RNA 
flows through the filter, protein binds the nitrocellulose and will retain any RNA 
complexed with it.  Indeed, in the absence of protein, RNA retention on the filter 
was generally less than 10% of total counts applied.   Using this assay, we 
determined that C87 and C90 bound RNA equivalently and with approximately 1 
µM affinity; a slight preference was seen for G and U homo-oligomers (Fig 3-4C).  
The low affinity and low specificity of capsid binding to RNA suggested a 
nonspecific, charge-charge interaction of the highly basic protein and negatively 
charged phosphate backbone of the nucleic acid. 
 
Systematic enhancement of ligand binding by exponential enrichment 
 To further investigate the involvement of specificity in capsid-RNA 
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Fig 3-4.  BVDV capsid binds RNA.  Binding of C87 (A) and C90 (B) to RNA
homo-oligomers.  Means and standard error of the mean (SEM) of at least 
duplicate binding assays are shown.  Curves are fit using sigmoidal variable
slope model.  (C) Dissociation constants for capsid binding to homo-oligomers.
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enrichment (SELEX) was employed.   In this approach an RNA library is enriched 
for sequences with high affinity for the target protein.   A random library of 25  
nucleotides with flanking T7 promoter and primer binding sites was created from 
synthesized oligonucleotide primers.  RNA transcribed from this library was 
screened for sequences better able to bind C87, as described in the materials 
and methods.  In the initial rounds of selection, the number of RNA molecules 
was kept at or above the theoretical complexity of the library (1 x 1015 
sequences).  At each round of selection, the affinity of the RNA population for 
C87 was measured and the pool was partitioned by binding to a low 
concentration of protein.  The protein-bound RNA was reverse transcribed (RT), 
PCR amplified, and used as a template for the synthesis of an enriched RNA 
pool for the next round of selection.  After eight rounds of selection, the RT-PCR 
amplified RNA pool was cloned and multiple individual colonies were sequenced.  
Although the affinity of the pool had not significantly increased during the 
selection, a consensus sequence emerged in all of the 13 clones sequenced (Fig 
3-5).  This sequence was not detected in 6 clones sequenced from the original 
library.   The consensus sequence, GUGGGA(A/U)NNA, is G-rich, in keeping 
with the slightly higher affinity for G observed in the homo-oligomer studies.  The 
lack of increased affinity of the pool is also consistent with the similar affinities of 
the homo-oligomers for capsid and again suggests that capsid binds RNA with 









































Fig 3-5. Selection of a consensus RNA for C87 binding.  (A)  Binding of 
round 1 and round 8 RNA pools to C87.  For round 1 binding mean and SEM
for triplicate measurements are shown.  (B)  Sequences of the randomized 
region of cloned cDNAs from round 8 of selection.  Consensus is shown; 
W, A or U; N, any nucleotide.
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such as nuclease resistance, could have also contributed to the emergence of a 
consensus sequence. 
Taken together, these results indicate that BVDV capsid binds RNA, but 
with low affinity and little specificity.  The slight preference for G could indicate a 
propensity to bind structured RNA molecules.   
 
C90 binds to 14 nucleotides of oligo-U RNA 
 Capsid protein binding to RNA appeared to be of low affinity and of low 
specificity.  To further investigate the nature of the capsid-RNA interaction, we 
determined the minimal RNA size that could act as a capsid binding site.  We 
used the filter-binding assay to quantify the ability of oligo-U sequences of 
different lengths to compete for U30 binding to C90; oligo-G was not chosen 
because of the possible complication of secondary structures.  In this assay the 
C90 concentration was held constant at approximately the Kd (0.75 µM), 
radiolabeled U30 concentration was also constant at approximately 100 pM, and 
unlabeled competitor was diluted from 3 mM to 50 nM.  While U6 was not able to 
compete for U30 binding, as the length was increased competition became more 
efficient (Fig 3-6).  From the competition assay, the binding site size for C90 to 
oligo-U RNA was estimated at 14 nucleotides.     
 To verify the binding site size, we conducted a direct filter-binding assay of 
labeled U14 or U30 to C90.  As observed previously, the binding affinity of C90 to 
U30 was approximately 1 µM.  The affinity of C90 binding to U14 was lower but 









































































































































































Fig 3-6.   C90 minimal RNA binding site size is 14 nucleotides.  Competition
for C90 binding to U30.  Residual U30 binding in the presence of the unlabelled
oligomers indicated.  Means and SEM of duplicate binding assays are plotted.
Curves are fit using one-site competition model.  
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binding was detectable (Fig 3-7A).  Analysis of the cooperativity of binding by Hill 
plot suggested that two molecules of C90 bind to U30 cooperatively, whereas a  
single molecule binds to U14 (Fig 3-7B).  This analysis is consistent with a 
minimal C90 binding site size of 14 nucleotides.   
 
BVDV capsid acts as a nonspecific RNA binding protein in vivo 
 Our in vitro analyses of BVDV capsid protein suggested a nonspecific, low 
affinity association with RNA.  We hypothesized that BVDV capsid might act as a 
nonspecific RNA binding protein in vivo, and that this type of interaction might 
allow it to condense and neutralize viral genomic RNA.  To test this hypothesis, 
we investigated whether BVDV capsid protein could functionally replace a known 
nonspecific RNA condensing sequence.  The well-documented RNA packaging 
activity of Sindbis virus capsid protein provided an ideal system for this 
investigation (Fig 3-8A).    
Sindbis genomes were created with in-frame deletions engineered into the 
amino-terminal domain of the capsid protein (Fig 3-8B).  The native sequence 
from amino acids 97 to 264 was maintained in all constructs, preserving the 
specific RNA interaction sequence and protease activity (155, 36).  In the largest 
deletion, the methionine start codon was fused directly to amino acid 97.  This 
genome was predicted to be severely impaired in RNA packaging and therefore 
in infectious virus production (60).  To test the ability of the BVDV capsid protein 
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Fig 3-7.  C90 binding to U14 and U30.  (A) Direct binding of C90 to radio-
labelled U14 (black) or U30 (white).  Mean and SEM of at least quadruplicate 
measurements are shown. Curves are fit using sigmoidal variable slope model.  
(B)  Hill plots of C90 binding to U14 (black) or U30 (white).  (C)  Slopes of Hill 
plots. 
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region, while preserving the approximate native length of the Sindbis capsid 
amino-terminal domain (Fig 3-8C).  The parental sequence was a fully infectious 
Sindbis virus genome encoding firefly luciferase as a fusion with the nsP3 
protein, facilitating sensitive detection of infectious virus production by reporter 
gene activity (Sindbis/luc, ref 19).   
In vitro generated RNA transcripts of each genome were electroporated 
into BHK 21 cells.  Wild-type Sindbis/luc and Sindbis/luc(ΔKpnI), a replication 
defective genome with a deletion in nsP4 (19), were electroporated in parallel.  
Replication was assayed at 6 h post-electroporation by quantification of 
intracellular luciferase activity.  Consistent with the non-essential role of Sindbis 
capsid in RNA replication, luciferase activities were similar for each of the mutant 
genomes; Sindbis/luc(ΔKpnI) did not replicate (Fig 3-9A).  Intracellular capsid 
protein expression was also measured at 6 h post-electroporation.  Western blot 
with anti-Sindbis capsid (168) and anti-BVDV capsid polyclonal antibodies (see 
materials and methods) confirmed the expression of the appropriate sequences 
(Fig 3-9B).  The reduced expression of Sindbis/luc(CΔ2-96) and related chimeras 
is likely due to the deletion of a translational enhancer present in the capsid 
coding sequence (61).  
At 24 h post-electroporation, cell culture supernatants were harvested, 
clarified by filtration, and used to infect naïve BHK 21 cells.  The infected cells 
were incubated for 4 h before assay for luciferase activity.  Sindbis/luc(CΔ2-96) 
was severely impaired in infectious virus production, while the less drastic 
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Fig 3-8. Sindbis and BVDV capsid proteins.  (A) Schematics of Sindbis, 
top, and BVDV, bottom, capsid protein functional domains.  (B) Deletions 
in Sindbis capsid protein created in the context of Sind/luc.  (C) Chimeras 
of Sindbis, white, and BVDV, grey, capsid protein sequences in the 










































































































Fig 3-9.  Chimeric genomes replicate and express chimeric capsid 
proteins.  (A) Luciferase activity in transfected cells after 6 h. Mean and 
SEM of duplicate experiments are shown.  (B) Protein expression at 6 h 
post-electroporation.  BVDV capsid, top panel, and Sindbis capsid, middle 
panel, detected using polyclonal antibodies.
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deletions, Sindbis/luc(CΔ50-96) and Sindbis/luc(CΔ72-96), showed more 
moderate reductions in infectivity (Fig 3-10A).  In each case, the inclusion of 
BVDV sequences increased the infectivity of the deletion mutants, indicating that 
the basic nature of the BVDV residues was sufficient to rescue infectious virion 
production.   In the case of Sindbis/luc(CΔ2-96/BVDV1-90), in which the entire 
virion associated form of BVDV capsid replaces the basic amino-terminus of 
Sindbis capsid, the infectivity was only about ten-fold reduced from wild-type 
Sindbis/luc (Fig 3-10A).  This strongly suggested that the BVDV capsid protein 
could functionally replace the Sindbis capsid amino-terminal domain.  
Interestingly, infectivity of Sindbis/luc(CΔ2-96/BVDV1-90) was markedly 
increased over that of Sindbis/luc(CΔ2-96/BVDV1-84) (Fig 3-10A).  The 
requirement for these carboxy-terminal six amino acids, which are actually not 
basic in nature and have predicted helical character, might point to an additional 
functional sequence within the BVDV capsid protein.    
 In order to verify that infectious virus production resulted from the 
electroporated mutant genomes and not reversions, lysates from infected cells 
harvested after 4 h (Sindbis capsid blot) or 24 h (BVDV capsid blot) were probed 
for expression of the viral capsid sequences with polyclonal antibodies.  Capsids 
of the appropriate provenance were detected in each infected cell population, 
indicating that the infectivities of the mutant genomes were accurately 












































































































Fig 3-10.  Infectivity of chimeric genomes.  (A) Luciferase activity in 
infected cells after 4 h. (B) Protein expression in infected cells.  BVDV 
capsid, top panel, detected at 24 h post-infection.  Sindbis capsid, middle 
panel, and β-actin, lower panel detected at 4 h post-infection.  
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Taken together, these results suggest that the nonspecific RNA binding 
properties of BVDV capsid observed in vitro are responsible for its ability to 
functionally replace an RNA condensation sequence in vivo and indicate that the 
BVDV capsid protein likely functions by a similar mechanism in packaging its 
own genomic RNA.   
 
Discussion 
Proteins involved in condensing, protecting, transporting and subsequently 
releasing a viral genome might be expected to bind RNA with low affinity and to 
efficiently neutralize its negative charge.  We have shown that the highly basic 
BVDV capsid protein demonstrates this behavior in vitro and can functionally 
replace the nonspecific RNA binding region of another viral capsid protein in vivo.  
The in vitro nonspecific RNA binding affinities of BVDV capsid and a portion of 
the Sindbis capsid amino-terminal region are similar, at approximately 0.5-0.6 µM 
(117).  This relatively low binding affinity likely allows the RNA genome to be 
released and accessed for translation upon entry into a new host cell.  The ability 
of BVDV capsid to functionally replace the role of the Sindbis capsid amino-
terminus in infectious virus production indicates not only a recapitulation of RNA 
binding and condensation activities, but also of appropriate genome release upon 
uncoating.    
While Sindbis virus capsid protein residues 97-106 interact specifically 
with an encapsidation signal in the genomic RNA (220, 155), BVDV capsid 
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appears to be far less discerning.  Although this could be an artefact of the in 
vitro experimental conditions, the ability of BVDV capsid to readily bind Sindbis 
RNA in vivo favors the hypothesis of largely ionic interactions.  This putative 
inability to discriminate between genomic, antisense, and cellular RNAs may be 
overcome by local concentration effects caused by intracellular 
compartmentalization of viral replication and assembly.  No evidence for a 
specific encapsidation signal has been found for any member of the Flaviviridae.   
While the amino-terminus of Sindbis virus capsid protein, and likely of 
other viral capsid proteins, appear to be functionally homologous to the BVDV 
capsid, the Pestivirus sequence has the unusual lack of a structured carboxy-
terminal domain.  In the absence of such a domain, it is difficult to envision how 
the BVDV capsid protein might be able to form a structured casing around the 
viral RNA.  Canonical viral nucleocapsids consist of an ordered array of capsid 
protein subunits, arranged symmetrically around the nucleic acid interior (88).  
These nucleocapsids, including those of Sindbis virus, can often be assembled in 
vitro from capsid protein and nucleic acid components, and visualized and 
isolated from infected cells.  Interestingly, non-enveloped nucleocapsids are 
rarely seen in Flavivirus or Pestivirus-infected cells (116), and limited studies of 
HCV have also so far failed to detect intracellular nucleocapsids (176).  This 
suggests that Flaviviridae cores may not be discrete, stable, proteinaceous coats 
for the viral genome.  Consistent with this, purification and in vitro assembly of 
Flaviviridae nucleocapsids have been extremely difficult, and usually result in 
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structures with pleiomorphic shapes and heterogeneous sizes (97, 105, CLM and 
CMR unpublished observations).   
Further evidence for an absence of defined symmetry in the nucleoprotein 
core of Flaviviridae particles comes from the cryo-EM image reconstructions of 
DENV and WNV, both members of the Flavivirus genus (Fig 3-11, ref 101, 145, 
232).  In these virion structures no discrete nucleocapsid was detected despite a 
defined symmetry of the outer envelope protein shell (101, 145, 232, 233).   In 
addition, no transmembrane connections between the envelope proteins and 
particle inner core were seen, suggesting a symmetry match between the two 
layers is likely not required (232).  The Flavivirus capsid protein dimers are 
predicted to be randomly dispersed within this disordered core, with their overall 
positive charge neutralizing the genomic RNA (147).  Infectious BVDV particles 
are known to be pleiomorphic in size and shape (70) and can contain genomes 
varying in size by over 8 kb (13), an extreme flexibility that might be inhibited by 
the constrained interactions of an icosahedral nucleocapsid.  In fact, the 
icosahedral core may be the exception rather than the rule among enveloped 
RNA viruses; nucleocapsids of the Coronaviruses are reported to be flexible, 
filamentous structures packed into a spherical virion outer shell (172).  
While the BVDV capsid lacks structural features found in other viral capsid 
proteins, these folded domains may not be necessary in the absence of an 
ordered nucleocapsid and specific genomic RNA interactions.  Interestingly, the 


























Fig 3-11.  Model for BVDV capsid function.  (A) Structure of Sindbis virus
(231) showing ordered nucleocapsid with partially disordered inner layer 
(arrow).  (B) Structure of West Nile virus (145) showing unstructured 
nucleocapsid.  (C)  Proposed functional domains of BVDV capsid.  Residues 
1-84 are highly basic, disordered residues available for RNA interactions.  
Residues 85-90 are hydrophobic residues proposed to mediate interactions 
between capsid proteins.  
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to be required for optimal replacement of the Sindbis virus capsid amino-terminus 
function.  Since a Sindbis capsid homotypic interaction domain was also deleted 
in these genomes (157), the possible compensation for this might suggest the 
presence of at least one other functional region in the BVDV capsid protein.  We 
propose that the hydrophobic resides 85 to 90 are involved in the mediation of 
capsid-capsid interactions (Fig 3-11).  This putative dimer formation is in keeping 
with our observed cooperativity of RNA binding and reminiscent of the functional 
dimers formed by other Flaviviridae capsid proteins (97, 130, 89, 25). 
In conclusion, we found that BVDV capsid is a natively unfolded protein 
with a large number of basic residues involved in mediating low affinity 
nonspecific interactions with RNA.  We further determined that this in vitro 














Chapter 4:  Mutagenesis of the HCV core protein reveals numerous 
residues essential for infectious virus production in cell culture 
 
Introduction  
 The HCV capsid protein, termed core, is presumed by analogy to the 
related Flaviviruses and Pestiviruses to function primarily as a component of the 
infectious virion (30).  Until very recently propagation of HCV in tissue culture has 
not been possible, and consequently, this major function of the core protein has 
not been investigated.  Initial sequence analyses of core indicated that this well 
conserved, 21 kDa, protein has numerous basic residues in its amino-terminal 
region, followed by a central hydrophobic domain, and a signal sequence for E1 
(Fig 4-1, ref 30, 132).  The identification of putative nuclear localization signals 
(30) led to numerous reports that core protein could regulate cellular and 
heterologous viral promoters (98, 186, 164, 166).  Suppression of the hepatitis B 
virus promoter was reported to occur in a phosphorylation dependent manner 
(185).  Since only carboxy-terminally truncated, rather than full-length, core 
proteins appear to localize to the nucleus, the ability of core to modulate gene 
expression remains controversial (116).   
 Processing events required for the production of the mature core protein 
have been intensively investigated.  The carboxy-terminal residue of the virion-
associated form of the protein, however, has yet to be unambiguously 

















Fig 4-1. HCV core protein seqeunce and features.
(A) J6 core amino acid sequence.  (B) Previously reported 
core functional regions (reviewed in reference 132). 
See text for details.
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microsomal membranes implicated signal peptidase and another host enzyme 
(180), later identified as SPP, as important for core processing  (133).  Attempts 
to identify the SPP processing site by mutation of the core protein have led to 
disparate conclusions.  This is likely because cleavage form resolution depends 
on the gel system chosen (82), and since purified core protein size standards 
containing the appropriate mutations have not been employed.  Cleavage of core 
by SPP has been shown to regulate the intracellular localization of the protein, 
liberating it from the ER membrane and allowing it to traffic to lipid droplets (133).  
Although overexpression systems have suggested the targeting of core to 
various compartments including the nucleus (186, 195) and mitochondria (182, 
195), recent studies of infected cells suggests the protein accumulates solely at 
lipid droplets and their associated membranes (176).   
In the absence of a full infectious system for HCV, production of virus like 
particles (VLPs) has been used to investigate assembly requirements.  Budding 
of enveloped particles containing short fragments of RNA could be induced by 
overexpression of core, E1, and E2 in insect and mammalian cells (12, 20).  
Electron microscopy revealed nucleocapsids in the process of budding through 
the membranes of ER-derived tubules, but the absence of particles in the 
supernatant indicated that this process was abortive (20).  Association of capsid 
and RNA into nucleocapsid like particles (NLPs) has been seen by core 
overexpression in yeast, in an in vitro translation-assembly system, and using 
recombinant protein (105, 99, 1).  These systems have been used to 
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demonstrate core interactions with itself and with RNA (25, 105, 99), and to 
suggest associations with the envelope glycoproteins (12). 
In addition to a high degree of amino acid conservation, the core coding 
sequence is well preserved among HCV isolates (30).  This conservation, 
originally speculated to maintain the expression of an alternate reading frame 
protein (216, 23), has now been shown to preserve RNA structures important for 
replication efficiency and infectivity in chimpanzees (134).  Additional RNA 
structures in the core coding region have been predicted, but not confirmed to be 
essential (211). 
The advent of the cell culture infectious systems allows role of core in 
virus life cycle to be studied for the first time.  Here we have performed a 
comprehensive deletion and alanine-scanning mutagenesis study of the core 
protein in the context of an infectious J6/JFH reporter virus.   We have confirmed 
that core protein is essential for infectious virion production, and have identified 
numerous residues critical for this activity.  Passage of assembly-defective core 
mutant genomes identified compensatory mutations in nonstructural proteins p7, 
NS2, and NS3.  The detection of genetic interactions between core and these 
proteins adds to accumulating evidence that nonstructural factors play important 




Characterization of a J6/JFH reporter virus 
To facilitate the analysis of core protein mutations, we utilized a recently 
developed J6/JFH reporter virus, J6/JFH(p7Rluc2A) (90).  This genome encodes 
Renilla luciferase followed by the foot and mouth disease virus (FMDV) 2A 
autoproteolytic peptide between p7 and NS2 (Fig 4-2A).  Since this virus was 
uncharacterized, we determined the validity of the reporter activity as an assay 
for replication and infectious virus quantification.  In vitro generated RNA 
transcripts were electroporated into Huh-7.5 cells and viral RNA replication was 
measured after 8, 24, 48 and 72 h by both luciferase assay (Fig 4-2B, left panel) 
and by quantitative RT-PCR (qRT-PCR) using a probe directed against the 
5’UTR of the viral genome (Fig 4-1B, right panel).  Whereas J6/JFH(p7Rluc2A) 
and a genome with a large in-frame deletion of the envelope proteins, 
J6/JFH(p7Rluc2A)/ΔE1E2, replicated similarly, a genome with a lethal mutation 
of the essential NS5A RNA-dependent RNA polymerase motif GDD to GND, 
J6/JFH(p7Rluc2A)/GND, did not replicate.  Luciferase activity closely reflected 
viral RNA accumulation, indicating the validity of the reporter for analysis of RNA 
replication.   
 Infectious particle production was assayed at 8, 24, 48, and 72 h post-
electroporation by inoculation of naïve Huh-7.5 cells with filtered cell culture 
supernatants.  Infectivity was quantified by luciferase assay of the infected cell 
lysates after 48 h, and by limiting dilution assay to determine a fifty-percent tissue  
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Fig 4-2.  Characterization of the J6/JFH(p7Rluc2A) reporter virus.
(A) A schematic representation of the full-length J6/JFH genome, top, and 
the J6/JFH(p7Rluc2A) reporter virus, bottom.  The J6/JFH(p7Rluc2A) genome 
has an insertion of Renilla luciferase and the foot and mouth disease virus 2A 
peptide between p7 and NS2. (B) Replication of J6/JFH(p7Rluc2A) (         ), 
J6/JFH(p7Rluc2A)/ΔE1E2 (     ) and J6/JFH(p7Rluc2A)/GND (     ) 
measured by luciferase activity.  (C) Replication measured by qRT-PCR 
analysis of RNA accumulation.  (D) Infectious virus production measured by 
luciferase assay of infected cells.  (E) Infectious virus production measured 
by limiting dilution assay (TCID50) at 8 (<30 TCID50/ml), 24 (<30 TCID50/ml), 









culture infectious dose (TCID50).   Whereas no virus was detected in culture 
supernatants of cells harboring J6/JFH(p7Rluc2A)/ΔE1E2  
or J6/JFH(p7Rluc2A)/GND, J6/JFH(p7Rluc2A) produced robust levels of 
infectious virus as assayed by either method (Fig 4-1C). These results indicate 
that luciferase activity is an appropriate reporter for both replication and infectious 
virus production of J6/JFH(p7Rluc2A).    
   
Core protein is essential for infectious virus production in HCVcc 
Core protein is thought to be an integral part of the HCV virion.  The extent 
to which deletions in core affect infectious virus production in the HCVcc system, 
however, is not known.  To determine the contributions of various regions of the 
core protein to infectious virus production, we engineered in-frame deletions of 
core between amino acids 57 and 160 into the J6/JFH(p7Rluc2A) genome.  
Residues before amino acid 57 were not included in the deletion analysis 
because of conserved RNA structures within this region important for replication 
(211, 134).  Similarly, amino acids 161-191 were left intact to ensure proper 
membrane targeting of E1 (180).  In vitro generated RNA transcripts of each 
genome were electroporated into Huh-7.5 cells.  Viral RNA replication was 
measured by assay of cell lysates for luciferase activity after 8 h and 48 h.   None 
of the seven partial deletions of core significantly affected RNA replication as 
compared to wild-type J6/JFH(p7Rluc2A); J6/JFH(p7Rluc2A)/GND did not 
























































































Fig 4-3.  Deletions in core abolish infectious virus production.  
(A) Replication of J6/JFH(p7Rluc2A) genomes with deletions in core.  
Replication was assayed by luciferase activity at 8 h, grey, and 48 h, 
black, post-electroporation. (B) Infectious virus production at 48 h post-
electroporation. Means and SEM of duplicate electroporations are shown.
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 Infectious particle production was assayed at 48 h post-electroporation by 
inoculation of naïve Huh-7.5 cells with filtered cell culture supernatants and 
luciferase assay of the infected cell lysates after 48 h.  In contrast to the robust 
infectious virus production of wild-type J6/JFH(p7Rluc2A), none of the genomes 
containing deletions in core produced detectable levels of infectious virus (Fig 4-
3B).  These data indicated that core protein is essential for infectious virus 
production and that this function is intolerant to deletions within the central region 
of the protein.   
 
Mutagenesis of conserved features of core 
 Sequence analysis of core, as well as data from overexpression systems, 
have suggested the importance of various conserved residues.  With the advent 
of the HCV tissue culture infectious system, the importance of these sequences 
in the viral life cycle can be investigated for the first time. 
 
Mutagenesis of putative phospho-serines   
 Initial analyses of the core amino acid sequence indicated the presence of 
a conserved phosphorylation motif at serine 99 (30).  Subsequent studies of core 
overexpression in insect and mammalian cells suggested phosphorylation of 
serines 53, 99, and 116 (185, 123).  The exact residues and kinases involved, 
however, as well as functional significance of the putative phosphorylation events 
remain controversial.  
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To investigate the importance of serines 53, 99, and 116 for HCVcc 
infectivity, we individually mutated these residues to alanine in the context of the  
J6/JFH(p7Rluc2A) reporter virus.  Whereas mutation of these amino acids did not 
affect RNA replication (Fig 4-4A), mutation of serine 99 to alanine (S99A) 
severely impaired infectious virus production (Fig 4-4B).  S53A and S116A 
mutations less significantly impacted infectivity (Fig 4-4B).  Mutation of each 
combination of two serines to alanine confirmed that serine 99 was the only 
residue absolutely required for infectious virus production (Table 1).  Mutation of 
each serine to aspartic acid, to mimic constitutive phosphorylation, abolished 
infectivity in all three cases (Table 1).  Mutation to another serine codon did not 
impact infectivity, suggesting that the defect caused by the S99A mutation was at 
the amino acid, and not RNA, level (Table 1).   
 These results suggest that serine 99 plays an essential role in HCV 
infectivity, and that phosphorylation, if it occurs, must be regulated rather than 
constitutive.  While the effect of the S99A mutation on core protein stability was 
not assayed directly, analysis of this mutation in the context of neighboring 
alanine-substitutions suggested the change did not impair core expression (see 
below).  Attempts to immunoprecipitate radiolabeled core protein from 
transfected cells were not successful, leaving the relevance of serine 99 

















































Fig 4-4.  Serine 99 is essential for infectious virus production. 
(A) Replication of J6/JFH(p7Rluc2A) genomes with serine to alanine 
substitutions in core at 8 h, grey, and 48 h, black, post-electroporation. 
(B) Infectious virus production at 48 h post-electroporation.  Means and 
SEM are shown for serine mutants, wild type and polymerase defective 
controls represent single electroporations.
a Assayed by immunohistochemical staining for NS5A
b Core serine mutated (J6/JFH polyprotein numbering)









































Mutagenesis of core amino acids 172 and 173 
 While the J6/JFH chimeric virus used in our studies has been found to be 
more infectious than JFH-1 alone (115, 235), the determinants of this enhanced 
infectivity are not known.  Comparison of J6 and JFH-1 core sequences identified 
an unusual mutation of a highly conserved C/S sequence to F/P at residues 
172/173 of the JFH-1 protein (93).  The identification of a second genome 
encoding the S173P change (JFH-2) led to speculation that mutations in this 
region might correlate with the fact that both these isolates came from patients 
with fulminant hepatitis, a rare acute clinical presentation with unknown relevance 
to the tissue culture infectious phenotype (93).  Since the J6 protein contains the 
canonical C/S sequence at amino acids 172/173, we hypothesized this core 
sequence might be a determinant of enhanced J6/JFH infectivity.  Interestingly, 
the C/S motif had been previously recognized to resemble an NS3 protease 
cleavage site (180, 2).  The presence of similar cleavage sites in related viral 
capsid proteins led to the speculation that, while host enzymes rather than NS3 
are responsible for processing of HCV core, binding of the viral protease might 
play a role in infectivity.  
To investigate the functional relevance of the C/S motif, we undertook a 
mutational analysis of these residues in the context of the J6/JFH(p7Rluc2A) 
reporter virus.  RNA replication, measured at 8 h and 48 h post-electroporation of 
Huh-7.5 cells with in vitro transcribed RNA, was not significantly affected by the 























































































































































































Fig 4-5.  Mutations of core C172/S173.  (A) Replication of J6/JFH(p7Rluc2A) 
genomes with substitutions of core C172/S173 at 8 h, grey, and 48 h, black, 
post-electroporation.  (B) Infectious virus production at 48 h post-
electroporation. Mutated residues are identified.  Means and SEM of at least 
duplicate electroporations are shown. (C) Western blot analysis of lysates 
harvested at 48 h post-electroporation.  Core, top panels, NS5A, middle panels, 
and β-actin, lower panels are shown.  Blots are representative of at least 
duplicate analyses from independent electroporations.
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infectious virus production was abolished by mutation of C172 to R, D, or N, and 
impaired by mutation of C172 to S, L, or F (Fig 4-5B).  Mutation of C172 or S173 
to alanine alone or in combination did not drastically affect infectivity.  Mutation of 
S173 to P, as in JFH-2, resulted in robust infectious virus production, as did 
mutation of C172/S173 to F/P, the JFH-1 sequence (Fig 4-5B).  Analysis of 
mutant core protein stability in transfected cell lysates harvested 48 h post-
electroporation indicated that the abolished infectivities of 
J6/JFH(p7Rluc2A)/C172D and J6/JFH(p7Rluc2A)/C172N were likely due to the 
absence of stable core expression (Fig 4-5C).  Other mutants, such as 
J6/JFH(p7Rluc2A)/C172R, were impaired in infectious virus despite near wild-
type core expression.   
These results suggested that the JFH-1 (C172F/S173P) and JFH-2 
(S173P) changes at residues 172/173 do not drastically impair infectivity of a 
J6/JFH genome, indicating that the identity of these residues is likely not a major 
determinant of enhanced J6/JFH infectivity.  Since the S173P change is 
predicted to be severely inhibitory to NS3-catalyzed proteolysis (100) and 
presumably binding (77), the finding that this change does not impact infectivity 
does not support the hypothesis of an essential role for NS3 binding to this region 
of core.        
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Alanine-scanning of core amino acids 57 to 191 reveals numerous residues 
critical for infectious virus production 
To more extensively investigate regions of core essential for infectious 
virus production, we performed a comprehensive mutagenesis of amino acids 57 
to 191 to alanine.  Residues were mutated in blocks of four amino acids in the 
context of the J6/JFH(p7Rluc2A) genome, and Huh-7.5 cells were electroporated 
with in vitro transcribed RNA generated from each construct.  RNA replication 
was measured at various time points post-electroporation by quantification of 
luciferase activity in the cell lysates; replication at 8 h and 48 h are shown (Fig 4-
6A).  In accordance with the results of the deletion analysis, none of the alanine 
mutations significantly affected RNA replication as compared to wild-type 
J6/JFH(p7Rluc2A), while J6/JFH(p7Rluc2A)/GND did not replicate (Fig 4-6A).    
To assay infectious virus production, naïve Huh-7.5 cells were inoculated 
with filtered supernatants harvested at 48 h post-electroporation and cell- 
associated luciferase activity was measured at 48 h post-infection.  Despite near 
wild-type levels of replication, the majority of the mutants were significantly 
impaired in infectious virus production, producing titers of less than 1%  wild-type 
J6/JFH(p7Rluc2A) (Fig 4-6B).  Exceptions were J6/JFH(p7Rluc2A)/C181-184A, 
J6/JFH(p7Rluc2A)/C185-188A, and J6/JFH(p7Rluc2A)/C189-191A which 
produced close to wild-type levels of infectious virus.  RT-PCR and sequencing of 
viral RNA isolated from cells infected with these viruses verified the presence of 






































































































































































































































































































Fig 4-6. Alanine-scanning mutagenesis of core.  (A) Replication of 
J6/JFH(p7Rluc2A) genomes with quadruple alanine substitutions in
core at 8 h, grey, and 48 h, black, post-electroporation.  (B) Infectious virus 
production at 48 h post-electroporation. Residues mutated to alanine are 
identified.  Means and SEM of at least duplicate electroporations are shown.
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numerous residues within the carboxy-terminal two-thirds for the core protein are 
dispensable for RNA replication but essential for robust infectious virus 
production.  
 
Some alanine mutations disrupt core stability 
We hypothesized that certain alanine substitutions may have destabilized 
the core protein, leading to the observed defects in infectious virus production.  
Cell lysates were analyzed at 48 h post-electroporation for the presence of core 
and NS5A by Western blot (Fig 4-7).  Core was detected using mAb HCM-071-5, 
which recognizes an epitope outside the region of mutagenesis.  NS5A was 
detected using mAb 9E10 (115).  While all replicating constructs expressed 
similar levels of NS5A, the stability of core protein varied among the alanine-
scanning mutants.  In those mutants that stably expressed core, levels of the 
protein were much the same as wild-type.  Exceptions were constructs 
J6/JFH(p7Rluc2A)/C161-164A and J6/JFH(p7Rluc2A)/C169-172A, in which core 
could be detected, but was significantly decreased compared to 
J6/JFH(p7Rluc2A) (Fig 4-7, lower panel).  With the exception of a possible 
uncleaved form visible on overexposure of the J6/JFH(p7Rluc2A)/C169-172A 
blot (Fig 4-7, lower panel), no differences in core processing were detected, 
although the ability of our gel system to resolve the cleavage products has not 
been established.  None of the mutants with undetectable core protein were 


























































































































































































































Fig 4-7. Stability of mutant core proteins.  Western blot analysis of lysates 
harvested at 48 h post-electroporation.  Core, top panels, NS5A, middle panels, 
and β-actin, lower panels are shown.  Residues mutated to alanine are 
identified.  Blot 11 lowest panel is an over exposure of the core blot 
demonstrating low levels of protein expression.  Blots are representitive of at
least duplicate analyses from independent electroporations.
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with the finding that core expression is essential for infectious virus production.  
These data indicated that, while about half of the alanine-substitution mutants 
were blocked at the level of stable core expression, many were severely impaired 
in infectious virus production despite wild-type levels of core protein.   
 
Alanine mutants do not produce noninfectious particles 
It was possible that mutations in core might lead to defects in entry, such 
as particle disassembly.  Those mutants that stably expressed intracellular core 
were further analyzed to determine whether they produced noninfectious virions.  
To assay for the release of noninfectious particles, RNA and core protein levels 
in the supernatant were determined.   To assess HCV RNA release, total RNA 
purified from cell culture supernatants 48 h post-electroporation was analyzed by 
qRT-PCR (Fig 4-8A).   Although limited amounts of RNA were detected in the 
supernatants of cells harboring the mutant genomes, the levels of RNA released 
were not significantly higher than those secreted by J6/JFH(p7Rluc2A)/ΔE1E2.   
This release of RNA by replication-competent genomes in the absence of 
infectious virus production has been reported previously (215).   
These data indicated that the core alanine-substitution mutants do not 
release substantial quantities of RNA-containing noninfectious particles.  To 
investigate whether particles lacking RNA were produced, core secretion was 
quantified.  Cell culture supernatants harvested at 48 h post-electroporation were 























































































































































Fig 4-8. Noninfectious particles are not released by core alanine-
substitution mutants.  (A) Total viral RNA release and (B) total core 
protein release at 48 h post-electroporation.  Only mutants with stable 
intracellular core protein were tested, residues mutated to alanine are 
designated. Means and SEM of at least duplicate electroporations are 
shown.
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None of the core alanine-substitution mutants produced drastically higher levels 
of secreted core than J6/JFH(p7Rluc2A)/ΔE1E2, suggesting that RNA-deficient 
noninfectious particles were not produced.   
 Taken together these data indicate that the majority of the core alanine-
substitution mutants are defective at a step after the accumulation of core protein 
and before the release of infectious or noninfectious particles. 
 
Isolation of compensatory mutations in the nonstructural proteins 
In an attempt to identify second-site changes that could compensate for 
the defective core proteins, cells harboring the mutant genomes were serially 
passaged.  Genomes encompassing alanine-substitutions between amino acids 
57 and 104 were selected for this analysis, as they appeared to be in a region of 
core in which protein stability was not compromised by the mutations (Fig 4-7).  
In order to avoid the emergence of second-site mutations related to the presence 
of the luciferase reporter gene, each of these quadruple alanine mutations was 
cloned into the non-reporter J6/JFH genome. For each construct the passaging 
experiment was conducted in duplicate. 
Because initial levels of virus production from these genomes were very 
low or undetectable, electroporated cells, rather than culture supernatants, were 
serially passaged (134).  Replication at each passage was monitored by 
immunohistostaining for NS5A.  While J6/JFH electroporated cells maintained a 
high proportion of NS5A-positive cells, those harboring genomes that could 
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replicate but not produce infectious virus had diminishing quantities of NS5A-
positive cells over time (data not shown).   For several of the genomes 
(J6/JFH/C65-68A, J6/JFH/C69-72A, and J6/JFH/C93-96A) the number of NS5A 
positive cells either did not diminish as rapidly or markedly increased during 
passage, indicating that infectious virus may have emerged.  Subsequently, cell 
free supernatants from these populations were passaged three times on naïve 
cells.  RNA harvested from the infected cells was then RT-PCR amplified and 
sequenced over the core to NS5A region.  For each of the mutants, the originally 
engineered alanine substitutions were maintained and a number of additional 
mutations were present; those that conveyed an infectious phenotype when 
individually reengineered into the parental alanine mutant are shown (Fig 4-9A 
and Table 2).  
          For J6/JFH/C65-68A, second-site mutations emerged at nucleotides 
T2666C (J6/JFH amino acid F776L, p7 F26L) and A3965G (J6/JFH amino acid 
T1209A, NS3 T178A).  The presence of the F776L mutation significantly 
increased infectious virus production of J6/JFH/C65-68A from undetectable 
levels.  The NS3 change, T1209A, while allowing detectable infectivity, very 
weakly rescued the core mutant (Fig 4-9B).  The J6/JFH/C69-72A genome 
produced very low titers of infectious virus in the context of J6/JFH(p7Rluc2A) 
(Fig 4-9B).  These titers were drastically increased by the presence of either of 
two emergent mutations, T2667C (J6/JFH amino acid F776S, p7 F26S) or 























Fig 4-9.  Compensatory mutations in nonstructural proteins are isolated 
by passaging.  (A) Putative topology diagram of the p7 to NS3 region of the 
HCV polyprotein. Positions of isolated mutations are designated.  (B) Infectious 
virus production at 48 h post-electroporation of core alanine-substitution mutants 
with or without compensatory mutations.  Infectious virus is detected by immuno-
histostaining for NS5A at 48 h post-inoculation of naïve cells.  Nuclei are counter-
stained with hemotoxylin-2.  Core mutations are designated on the left, additional 
mutations described above.  All mutations are J6/JFH polyprotein numbering.
a J6/JFH changes isolated
b Equivalent numbering in H77 genotype 1a consensus sequence
c  Polyprotein numbering (amino acid, aa); genome



























Table 2.   Isolated compensatory mutations. 
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J6/JFH/C69-72A was the only genome in which both replicate experiments 
produced revertant viruses, with F776S isolated from one population and A880P 
from the other.  This genome also reverted the most quickly, in three passages 
as opposed to six.  The J6/JFH/C93-96A genome also produced very low titers in 
the J6/JFH(p7Rluc2A) background (Fig 4-9B).  Infectious virus production was 
slightly increased by the emergence of the T2667C (J6/JFH amino acid F776S, 
p7 F26S) mutation (Fig 4-9B).     
These data suggest that mutations in the nonstructural proteins are 
capable of overcoming severely inhibitory mutations in the core protein.  It is 
interesting to note that a mutation of p7 (F776) emerged independently in each of 
the passaged genomes.  This mutation maps to within the first transmembrane 
domain of p7; the NS2 mutation also maps to a putative transmembrane region 
(Fig 4-9A).   
 
Compensatory changes in p7 and NS2 overcome an infectious particle 
assembly defect of the parental core mutants 
We next quantitatively analyzed the effects of the nonstructural protein 
changes on the parental core mutants.  Replication was monitored by qRT-PCR 
analysis of total cellular RNA at various time points after electroporation (Fig 4-
10A).  No significant differences in RNA replication were seen for the core 
alanine-substitution mutants, in the presence or absence of the compensatory
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Fig 4-10. Compensatory mutations rescue core alanine-substitution 
mutants.  (A) Replication of J6/JFH genomes with core alanine substitutions and 
the presence or absence of compensatory mutations at 8, 24, 48 and 72 h post-
electroporation (light grey to black, respectively). Replication was measured by 
qRT-PCR analysis of RNA accumulation. (B) Infectious virus production at 48 h 
post-electroporation measured by limiting dilution assay (TCID50).  (C) RNA 
secreted into the supernatant at 72 h post-electroporation as measured by qRT-
PCR.  (D) Intracellular infectious virus accumulation at 72 h post-electroporation 
as measured by quantification of RNA replication in infected cells by qRT-PCR at 





































































































































































mutations, as compared to wild-type J6/JFH.  These data suggested that the 
nonstructural mutations did not act at the level of RNA replication. 
Infectious titers of the core alanine-substitution mutants, with or without 
the compensatory mutations, were quantified by limiting dilution assay.  As seen 
in the context of J6/JFH(p7Rluc2A), the core mutants produced less than 1% of 
wild-type titers.  J6/JFH/C65-68A was especially impaired, with no detectable 
infectious virus produced (Fig 4-10B).  The presence of the second-site changes 
drastically increased the titers of J6/JFH/C65-68A and J6/JFH/C69-72A, with 
J6/JFH/C69-72A/A880P titers reaching almost wild-type levels.  J6/JFH/C93-96A 
was not as efficiently rescued by the presence of the F776S change, indicating 
that the same p7 mutation had disparate effects on two different core mutations. 
RNA release correlated with infectious virus titers, suggesting that increased 
secretion of total, including noninfectious, particles did not account for rescue of 
the core defects (Fig 4-10C). 
Although the core alanine-substitution mutants were defective in the 
release of infectious particles, it was possible that they supported assembly of 
intracellular infectious particles but were defective in egress.  To determine if the 
compensatory mutations acted at the level of secretion, cells were washed and 
lysed by multiple freeze thaw cycles at 72 h post-electroporation.  Cleared lysate 
was used to infect naïve cells and infectivity was quantified by analysis of RNA 
levels in the infected cells after 48 h.  Core mutants J6/JFH/C65-68A, 
J6/JFH/C69-72A, and J6/JFH/C93-96A did not produce significant levels of 
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intracellular infectivity, indicating that these mutants were impaired before 
infectious particle assembly (Fig 4-10D).  The presence of the compensatory 
mutations increased intracellular infectious virus production in proportion to the 
increased extracellular titers.  These data suggest that the core mutants are 
blocked at an early step of infectious virion production and that the p7 and NS2 
second-site changes can overcome this defect.  The more drastic effects of the 
F776L/S mutations on J6/JFH/C65-68A and J6/JFH/C69-72A as compared to the 
slight enhancement of J6/JFH/C93-96A infectivity suggests that a core-specific 
mechanism may account for this rescue of infectivity. 
 
Characterization of p7 and NS2 mutations in wild-type virus 
It was possible that the nonstructural protein changes might increase the 
fitness of wild-type virus, and that this enhancement could result in the 
suppression of core defects.  To test this hypothesis we engineered the F776L, 
F776S, and A880P mutations into the wild-type J6/JFH genome and analyzed 
replication at various times post-electroporation by qRT-PCR (Fig 4-11A).  None 
of the nonstructural protein mutants differed significantly in replication kinetics 
from J6/JFH.  This again indicated that the compensatory mutations did not act 
by increasing RNA replication. 
 Infectious virus titers were determined by limiting dilution assay of cell 
culture supernatants harvested at 72 h post-electroporation.  J6/JFH/F776L, 







































































































































Fig 4-11. Analysis of compensatory mutations in wild-type J6/JFH.
(A) Replication of J6/JFH genomes with nonstructural protein mutations at 8, 
24, 48 and 72 h post-electroporation, light grey to black, respectively. Replication 
was measured by qRT-PCR analysis of RNA accumulation. (B) Infectious virus 
production at 72 h post-electroporation measured by limiting dilution assay 
(TCID50).  (C) Specific infectivity of particles released 72 h post-electroporation.  
Measured by division of released RNA copies/ml by TCID50/ml.  (D) Intracellular 
infectious virus accumulation at 72 h post-electroporation as measured by
quantification of RNA replication in infected cells by qRT-PCR at 48 h post-
inoculation.  Means and SEM of duplicate electroporations are shown.
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produced titers approximately three-fold higher than J6/JFH (Fig 4-11B).  The  
specific infectivity of the particles was determined by relating released RNA 
copies/ml to the infectious titer.  The specific infectivity of wild-type J6/JFH was 
similar to that previously reported (115) and did not differ significantly from 
genomes containing the nonstructural protein changes (Fig 4-11C).  These data 
indicated that the presence of the p7 and NS2 mutations led to minimal 
enhancements of wild-type virus infectivity. 
 We next tested whether the presence of the nonstructural protein changes 
affected the accumulation of intracellular infectious virus.  At 72 h post-
electroporation, cells were lysed by multiple freeze thaw cycles and the clarified 
lysates used to infect naïve cells.  Infectivity was measured by qRT-PCR analysis 
of the infected cells after 48 h.   The presence of the p7 or NS2 mutations 
resulted in slight increases in intracellular infectivity as compared to J6/JFH, with 
J6/JFH/A880P producing almost four-fold wild-type levels (Fig 4-11D).  The 
levels of intracellular infectivity correlated well with extracellular infectious titers.   
 The minimal enhancement of J6/JFH fitness in the presence of the F776S 
or F776L changes again suggests that these mutations may specifically 
compensate for defects in core amino acids 65-72, and to a lesser extent core 
residues 93-96.  The A880P mutation, while capable of more significant 
enhancement of wild-type infectivity, may also be involved in a specific genetic 
interaction with core protein, as the effect of this mutation on J6/JFH/C69-72A is 
drastically greater than on J6/JFH.  
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Characterization of the NS3 compensatory mutation in core mutant and 
wild-type virus 
A T1209A change in NS3 was isolated by passage of J6/JFH/C65-68A.  
Whereas J6/JFH/C65-68A was highly defective in infectious virus production, the 
presence of the reengineered NS3 compensatory mutation resulted in infectious 
virus production reproducibly detectable by immunohistochemical staining for 
NS5A (Fig 4-9B).  Attempts to quantify the rescued virus by limiting dilution 
assay, however, resulted in titers below the limit of detection (30 TCID50/ml, Fig 
4-12B).  To investigate how the T1209A change might render J6/JFH/C65-68A 
infectious, however inefficiently, we analyzed the RNA replication of wild-type 
and core mutant genomes in the presence or absence of the T1209A change.  
Similar replication efficiencies were seen for genomes with or without the NS3 
mutation, suggesting this change did not act at the level of RNA accumulation 
(Fig 4-12A).  We next tested whether the T1209A substitution increased 
infectious virus production in a wild-type genome.  Titers of J6/JFH/T1209A were 
slightly higher than those of J6/JFH at 48 h post-electroporation, while at 72 h 
post-electroporation infectious virus release was similar for the two genomes.  
These results suggested that the T1209A change was likely acting as a weak 
general enhancer of J6/JFH infectious virus production. 
 To determine if the T1209A mutation might also increase the infectivity of 
the released particles, the specific infectivity of virions released at 72 h post-
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Fig 4-12. Analysis of the NS3 compensatory mutation in core mutant and 
wild-type virus.  (A) Replication of J6/JFH genomes with nonstructural protein 
mutations at 8, 24, 48 and 72 h post-electroporation, light grey to black, 
respectively.  Replication was measured by qRT-PCR analysis of RNA 
accumulation.  (B) Infectious virus production at 48 h (white) and 72 h (grey) 
post-electroporation measured by limiting dilution assay (TCID50).  For genomes 
not producing infectious virus, only titers at 48 h were measured.  (C) Specific 
infectivity of particles released 72 h post-electroporation, as measured by division 
of released RNA copies/ml by TCID50/ml.  (D) Intracellular infectious virus 
accumulation at 72 h post-electroporation as measured by quantification of RNA 
replication in infected cells by qRT-PCR at 48 h post-inoculation.  Means and 































































































































































electroporation was calculated.  Rather than rendering wild-type J6/JFH more 
infectious, J6/JFH/T1209A actually slightly increased the number of viral 
genomes per infectious unit (Fig 4-12C), suggesting it did not act at the level of 
particle infectivity.  We next tested whether T1209A increased the accumulation 
of infectious intracellular virus by lysis of cells by freeze-thaw at 72 h post-
electroporation.  J6/JFH and J6/JFH/T1209A showed similar levels of intracellular 
infectious virus (Fig 4-12D).  In the J6/JFH/C65-68A background, the T1209A 
change slightly increased intracellular infectivity of the core mutant, but not 
significantly above J6/JFHΔE1E2 background levels.  Taken together, these 
results suggest that T1209A might weakly increase J6/JFH infectious virus 
production, and that this slight enhancement could lead to the augmentation of 
J6/JFH/C65-68A infectivity.   
 
Additional characterization of the block of alanine-substitution mutants 
 To investigate how changes in the nonstructural proteins might 
compensate for mutations in core, we attempted to further define the stage of 
virion morphogenesis at which mutants J6/JFH/C65-68A, J6/JFH/C69-72A, and 
J6/JFH/C93-96A were impaired.   
 
Core mutants localize to lipid droplets 
 Wild-type core protein has been reported to localize to lipid droplets within 
an infected cell (7).  To determine whether J6/JFH(p7Rluc2A)/C65-68A, 
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J6/JFH(p7Rluc2A)/C69-72A, and J6/JFH(p7Rluc2A)/C93-96A core proteins were 
also localized to these structures, cells transfected with each of these genomes 
were analyzed by immunofluorescent staining.  Core protein was detected using 
mAb HCM-071-5, previously shown by Western blot to efficiently recognize each 
of these mutant proteins (Fig 4-7).  Lipid droplets were stained with Oil red O 
(84).  Visualization of stained cells by confocal microscopy indicated that core 
could colocalize with lipid droplets similarly in the presence or absence of the 
engineered mutations (Fig 4-13).  These results were consistent with previous 
reports that sequences carboxy-terminal to amino acid 122 mediate lipid droplet 
localization (84, 24).  Core mutants J6/JFH(p7Rluc2A)/C65-68A, 
J6/JFH(p7Rluc2A)/C69-72A, and J6/JFH(p7Rluc2A)/C93-96A, therefore, 
appeared to correctly localize to putative sites of assembly in the absence of 
compensatory mutations. 
 
Core mutations do not allow for temperature-dependent infectivity 
 If the alanine-substitutions in core impaired interactions of the protein with 
other components of the assembly pathway, lowering the temperature, and 
thereby increasing the stability of those associations, might allow infectious virus 
to be produced.  Cells electroporated with J6/JFH(p7Rluc2A)/C65-68A, 
J6/JFH(p7Rluc2A)/C69-72A, or J6/JFH(p7Rluc2A)/C93-96A genomes were 
grown at 28°C or 37°C for 4 days.  Replication, quantified by luciferase assay of 
transfected cell lysates, was again found to be similar between wild-type 
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Fig 4-13.  Core localizes to lipid droplets.  Cells fixed at 4 days post-
electroporation were stained for core with mAb HCM-071-5, left panels, and for 
lipid droplets with Oil red O, middle panels.  Samples were analyzed using Zeiss 
LSM 510 confocal microscope and associated software.  Histograms, right panel, 
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J6/JFH(p7Rluc2A) and the core mutants at 37°C (Fig 4-14A).  Although all 
genomes, with the exception of J6/JFH(p7Rluc2A)/GND, replicated at 28°C, 
greater variability was seen at the low temperature, possibly because of 
extremely slow cell growth (Fig 4-14A).   
 Infectious virus production was quantified 4 days post-electroporation by 
inoculating naïve cells with filtered supernatants and culturing at 37°C for 48 h.  
Similar to previous results, J6/JFH(p7Rluc2A)/C69-72A and 
J6/JFH(p7Rluc2A)/C93-96A produced infectious titers of less than 1% of wild-
type, and no infectious virus was detected for J6/JFH(p7Rluc2A)/C65-68A.  
Infectious virus production at 28°C was not enhanced in any of the mutant 
genomes, although J6/JFH(p7Rluc2A)/C93-96A was able to produce titers similar 
to the reduced wild-type levels at this temperature.  These results suggested that 
nonspecific enhancement of interactions by reduced temperature was not able to 
induce robust infectivity of the core mutant genomes.  The caveat of significant 
impairment of cell growth at 28°C, however, suggested that further optimization 
might yield a permissive temperature.   
 
Amino acids 65-72 are not amenable to the insertion of epitope tags 
 We were able to isolate compensatory mutations capable of rescuing 
neighboring core sequences 65-68A and 69-72A.  This suggested that this region 
of the protein might have a general flexibility amenable to the insertion of epitope 



































































Fig 4-14.  Core mutants are not temperature sensitive.  
(A) RNA replication at 28oC, grey, and 37oC, black, at 4 days 
post-electroporation.  (B)  Infectious virus production from cells 
grown at 28oC, grey, or 37oC, black, at 4 days post-
electroporation. Infections were performed at 37oC in each case.  
Means and SEM of duplicate experiments are shown.
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HA epitope tags replaced amino acids 65 to 72 or 73 of core (Fig 4-15).  
Immunohistostaining for NS5A expression indicated that the presence of the 
epitope tags did not affect RNA replication, but that infectious virus production 
was reduced to below the limit of detection (Fig 4-15).  Since alanine mutations in 
this region of core had also been deleterious to infectivity in the absence of 
compensatory mutations, we passaged cells harboring tagged genomes with the 
hopes of selecting for similar second-site mutations but without success (data not 
shown).  These results indicated that amino acids 65-72 of core are not 
amenable to extensive mutation and that the ability to select for compensatory 
mutations may depend on more subtle changes in this region.   
 
Core mutations do not affect particle stability 
 Mutations in core might be envisioned to impair interactions of the protein 
with components of the virion itself.  The residues mutated in 
J6/JFH(p7Rluc2A)/C93-96A lie within a proposed homotypic interaction domain 
(154), and all three groups of mutations are in close proximity to a putative 
glycoprotein association region (151), and RNA binding sequences (180).  To 
test whether incorporation of mutant core proteins led to virions of reduced 
stability, J6/JFH/C65-68A, J6/JFH/C69-72A, and J6/JFH/C93-96A viruses, 
produced in the presence of their isolated compensatory mutations, were 
incubated at elevated temperature (47°C) for various amounts of time.  The 
proportion of residual infectivity was quantified by qRT-PCR analysis of 











Fig 4-15.  Insertion of epitope tags in core abolishes infectivity.  
Schematics of epitope tags within core in the J6/JFH genome. 
Replication and infectious virus production from each genome 
at 48 h post-electroporation are indicated.
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intracellular RNA at 48 h post-infection of naïve cells.  With the exception of the 
slightly decreased stability of J6/JFH/C69-72A/A880P, the mutant core proteins 
did not appear to significantly affect virion integrity (Fig 4-16).  These results 
indicated that the core protein mutations do not affect contacts that are critical for 
the stability of the particle.  It is still possible, however, that these regions of core 
are required for structural component interactions early in assembly but that 




The advent of a tissue culture infectious system for HCV has allowed the 
role of the core protein in authentic virion production to be studied for the first 
time.  Here, we have performed a comprehensive deletion and mutational 
analysis of core and identified numerous sequences essential for infectivity.  
Consistent with the ability of subgenomes lacking the structural proteins to 
replicate autonomously (21), we did not identify any core mutants with replication 
defects.  Although core is not required for replication, mutations in conserved 
RNA structural elements within the core-coding region can affect replication in a 
full-length genome (134).  We excluded from our analyses the coding regions of 
residues 1 to 56, which have been shown to contain functional RNA structural 
elements  (134).  The possible phenotypic contribution of RNA structure to 
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Fig 4-16. Core mutations do not affect virion stability.  Virions 
containing mutant core proteins, rendered infectious by the presence
of the indicated nonstructural protein changes, were incubated at 47oC 
for the indicated periods of time.  Residual infectivity, as measured by 
qRT-PCR quantification of RNA replication in infected cells, is shown.  
Wild-type J6/JFH (         ) and mutants (         ).
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Despite robust RNA replication, the majority of alanine-substitution 
mutants showed severely impaired virion production (summarized in Fig 4-17).  
Notably, mutation of the carboxy-terminal residues 181-190 did not significantly 
impact infectivity.  These residues contribute to the E1 signal sequence, a known 
substrate of SPP (133). The tolerance of this region to mutation suggested that 
SPP cleavage might occur amino-terminal to these residues, or that the alanine 
substitutions in this region did not affect the efficiency of SPP processing.  
Previously, mutation of A180/S183/C184 to V/L/V has been suggested to abolish 
SPP processing of core (133, 3, 82).  It is possible that substitution of these 
amino acids with alanine, rather than with the bulkier leucine or valine did not 
disrupt SPP cleavage.  Consistent with this hypothesis, transmembrane regions 
containing helix-disrupting residues with small side chains have been shown to 
be optimal substrates for SPP (112), with the small side chain deemed sufficient 
in some reports (199).  Alternately, residues 180-184 may not play a role in SPP 
processing in the HCVcc system.  Interestingly, we found that mutation of 
residues 169-172 to alanine led to the production of very low levels of core that 
appeared to be incompletely processed.  Notably, this sequence contains three 
conserved small or helix-disrupting residues (PGC) (30).  It is also possible that 
SPP processing is disrupted by the carboxy-terminal alanine-substitutions, but 
that this cleavage is not required for infectious particle production.  Although 
studies of related viruses and analysis of core from HCV-infected patient sera 






























Fig 4-17. Summary of core alanine-scanning mutagenesis.
(A) J6 core amino acid sequence.  (B) Previously reported core functional 
regions (reviewed in reference 132).  (C) Summary of results of alanine-
scanning mutagenesis of residues 57-191.  Infectious virus production 
indicated by shading: black, 50-100% J6/JFH(p7Rluc2A); grey, 0.3-1% wild-
type.  Residues highlighted by dashed box did not produce stable core protein.  
Isolation of compensatory mutations indicated by stars.  Residues mutated
to alanine are numbered above.
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studies of NLP assembly have found SPP processing to be dispensable for 
budding (213, 128).  Also unknown is whether the core signal sequence performs 
additional roles after its liberation by SPP.  The insensitivity of this region to 
alanine-substitutions suggests it likely acts solely as a signal sequence, although 
it is possible that additional functions can accommodate these mutations.   
A number of the alanine-substitution mutations severely affected the 
expression or stability of the core protein (Fig 4-17).  These low or undetectable 
levels of core presumably led to the inability of these mutants to produce 
infectious virus.  Several studies have reported that mutations, deletions, or 
truncations of the central hydrophobic domain of core lead to proteosome-
mediated degradation of the protein (83, 196, 24, 133, 85).  This instability has 
been suggested to result from impaired association of these mutants with 
membranes and lipid droplets (133).  The amino-terminal domain of core, 
recognized as the first 117-120 amino acids (25, 132), is highly basic, flexible, 
and likely functions in binding and packaging the genomic RNA (25, 106, 105).  
Not surprisingly, the majority of mutations in this region did not lead to protein 
destabilization.  Interestingly, the sensitivity of residues following amino acid 105 
to mutation suggested that the highly flexible domain might be shorter than 
previously predicted. 
 Second-site mutations in nonstructural proteins p7, NS2, and NS3 were 
found to rescue the infectivity of several core alanine-substitution mutants by 
overcoming an early defect in virus morphogenesis, after the accumulation of 
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core at lipid droplets but before the assembly of an infectious particle 
(summarized in Fig 4-18).  p7 is an integral membrane protein with two helical 
transmembrane domains and a short basic cytosolic loop (32).  p7 has been 
shown to oligomerize, to form ion conductive channels in vitro (72), and to be 
essential for infectious virus production (179, 90).  Here, mutations of p7 residue 
F776 to L or S was found to dramatically enhance infectivity of J6/JFH/C65-68A 
and J6/JFH/C69-72A, respectively, while an independently isolated F776S 
mutation had a much less significant ability to rescue infectivity of J6/JFH/C93-
96A.  These observations, along with the limited effects of F776 mutations on 
wild-type virus, suggested that F776 might be involved in a specific genetic 
interaction with core amino acids 65-72.  This p7 residue is well conserved 
among HCV genotypes, with L, V or I also represented.  Interestingly, a 
sequence encoding the F776S mutation has recently been isolated from a patient 
infected with a genotype 1a virus (33).   
Structural modeling of p7 has suggested that F776 resides on the 
phenylalanine-rich face of transmembrane helix 1 (40, 32).  Both hexameric and 
heptameric models of p7 oligomeric ion channels predict that F776 faces out of 
the pore, and possibly stabilizes interactions with transmembrane domain 2 (156, 
40).  This positioning of F776 could leave it accessible for interactions with other 
membrane-associated proteins, including core.  Interaction of p7 with the 
structural proteins has recently been suggested by studies of intergenotypic 
chimeras in which homology of p7 and upstream sequences enhanced infectious 
Fig 4-18.  Core alanine-substitution mutants are blocked 























virus production (159).  Our finding that incorporation of mutant core proteins did 
not disrupt interactions required for virion thermostability suggested that these 
sequences might interact with nonstructural, rather than structural, proteins.  
While a direct interaction of p7 and core might be envisioned for the hydrophobic 
amino acids 93-96, however, the basic nature of wild-type core amino acids 65-
72 argues against their accessibility to p7 intramembrane sequences.   
Alternately, compensatory mutations in p7 might act to increase 
interactions of core with any of the numerous factors involved in the production of 
an infectious particle.  Determinants in transmembrane domain 1 have been 
shown to influence the delayed or incomplete processing of p7 from both E2 and 
NS2 (31).  Putative disruption of transmembrane helix 1 or destablization of 
interactions between the transmembrane domains might be envisioned to 
increase processing of p7 intermediates, thereby increasing concentrations of E2 
and NS2 available for assembly functions (31).  A recent report of core binding to 
E1 has suggested that this interaction depends on core amino acids 72 to 91 
(151), a region closely apposed to the alanine-substitution mutations in all three 
of the rescued genomes described here. The effects of the core mutations on E1 
binding, and a possible role for p7 in modulation of these processes remain to be 
investigated. 
An independent compensatory mutation in NS2 was isolated by passage 
of the J6/JFH/C69-72A genome.  NS2 is a membrane-associated cysteine 
protease and immediately follows p7 in the viral polyprotein (67).  Although the 
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exact topology of NS2 is disputed, the A880P mutation would be predicted to lie 
within the third transmembrane or membrane associated helix (226).  Residue 
880 is predominantly L, with V also represented and A prevalent in genotype 2 
sequences.  Proline in this position has not been reported, consistent with its 
predicted helical environment.  Unlike the p7 changes, the A880P mutation 
significantly increased infectious virus production in the context of a wild-type 
genome.  While this increase was much less dramatic than the corresponding 
enhancement of J6/JFH/C69-72A infectivity, it suggested that this adaptive 
mutation might act solely by overcoming a threshold of viral fitness, thereby 
suppressing the defective core phenotype.  Alternately, the A880P mutation 
might mediate specific genetic interactions with core amino acids 69-72, in 
addition to a general enhancement of infectivity.  Recent studies of intergenotypic 
chimeras have suggested that optimal infectivity requires NS2 transmembrane 
domain 1 and the structural proteins to be of the same genotype, as well as 
homology between the remainder of NS2 and the replicase proteins (159).  While 
the normal RNA accumulation of J6/JFH/A880P suggested that interactions 
required for replication were not affected, association of NS2 with NS3 could be 
envisioned to affect infectious virus production, as found in the related 
Pestiviruses (2).     
A compensatory mutation in NS3 was found to very slightly improve the 
infectivity of J6/JFH/C65-68A, likely through a weak, general increase in J6/JFH 
infectious virus production.  This T1209A change resides between the protease 
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and helicase domains of NS3.  Residue 1209 is predominantly M, with T 
prevalent in genotype 2A.  Alanine can be found in other genotype 2 and 
genotype 3 sequences.  A role for NS3 in HCV infectious virus production has 
recently been alluded to by the isolation of a Q1251L change that enhanced 
infectivity of an intergenotypic chimera (228).  Involvement of NS3 in infectious 
virus production has also been documented in the related Flaviviruses and 
Pestiviruses (103, 2).  Interestingly, recent microscopy studies have suggested 
that NS3 colocalizes with core on lipid droplets (176).   
In conclusion, a comprehensive mutagenesis study of the HCV core 
protein has identified numerous residues critical for its role in virion production. 
The identification of compensatory mutations in p7 and NS2 that efficiently 
overcome several defects imposed by core protein mutation illustrates the central 
role of these nonstructural proteins in virion morphogenesis.  The isolation of a 
weakly enhancing compensatory mutation in NS3 suggests that, as for other 
Flaviviridae, this multifunctional protein might also be involved in infectious virus 





Chapter 5:  BVDV infectious virus production depends on nonstructural 
protein determinants  
 
Introduction 
 BVDV nonstructural proteins NS2 and NS3 are multifunctional sequences 
with essential and not yet fully understood roles in many aspects of the viral life 
cycle (Fig 5-1).  NS2 is a 54 kDa protein with a hydrophobic amino-terminus 
containing multiple transmembrane segments and a cytosolic carboxy-terminal 
protease domain (108).  NS3 is a 76 kDa protein with an amino-terminal protease 
domain and a carboxy-terminal helicase/NTPase domain (217, 224, 197).  It does 
not possess a transmembrane segment but is membrane associated, likely 
through interactions with NS4A (201).   
 
Polyprotein processing 
Along with Npro, NS2 and NS3 constitute the viral proteases and are 
essential for the processing of the precursor polyprotein.  NS2, an autoprotease, 
catalyzes a single cleavage of its own carboxy-terminus from NS3.  Subsequent 
inhibition of its protease activity is predicted to result from irreversible binding of 
the processed carboxy-terminus to the active-site (109).  The NS2 protease 
activity is dependent on a cellular cofactor, Jiv (J-domain protein interacting with 
viral protein, ref 171, 107).  Jiv is an ER-associated, J-domain-containing 
chaperone protein related to Hsp40 (171).  Little is known about its mechanisms 
























Fig 5-1.  Functions of NS2 and NS3 in the BVDV life cycle.  NS2 and NS3 
are proteases required for polyprotein processing. Jiv, a cellular cofactor, 
grey.  NS3 is required for RNA replication.  NS2-3 cleavage, with NS4B modu-
lates the cytopathic effect.  Uncleaved NS2-3 is required for infectious virus 
production.  NS2-3 cleavage correlates with fatal disease in infected animals.
 140 
been implicated in the transport of the dopamine receptor to the cell surface (18).  
Jiv interacts with NS2 in the vicinities of both the active-site and the scissile bond 
and is thought to appose these domains in a conformation that facilitates 
cleavage (109).  Unlike a canonical chaperone activity, Jiv does not dissociate 
from NS2 after NS2-3 processing and therefore becomes unavailable for further 
activities as a cofactor (107).  Since intracellular levels of Jiv expression are low, 
titration of this limiting cofactor leads to increasingly inefficient NS2-3 cleavage, 
and the accumulation of an uncleaved NS2-3 product during the course of 
infection (107).   
The NS3 protease also has autocatalytic activity and processes its own 
carboxy-terminus from NS4A (224).  Unlike NS2, however, NS3 is not 
subsequently inactivated and goes on to cleave at additional downstream sites, 
liberating the nonstructural proteins from the polyprotein (224, 225, 201).  NS4A 
is a required cofactor for the NS3 protease activity, possibly because of its ability 
to tether NS3 to the ER membrane or by a conformational change-induced 
activation (224, 201, 44).    
 
Replication 
Naturally occurring BVDV genomes that have deletions of the first two 
nonstructural proteins (p7 and NS2), as well as the structural proteins, replicate 
autonomously and can be packaged into virions in the presence of a coinfecting 
helper virus, eliminating the possibility of an essential function for NS2 in RNA 
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replication (16).  When NS2 is present in a genome, however, its autoproteolytic 
cleavage from NS3 is absolutely required for RNA replication (108).  
Both the protease and helicase/NTPase activities of NS3 are essential for 
RNA replication (225, 69).  The protease activity of NS3 is required for correct 
maturation of the replicase proteins, including the RNA-dependent RNA 
polymerase (NS5B), and the helicase/NTPase domain may be involved in 
unwinding RNA secondary structures.   The inhibitory effect of a catalytically 
inactive NS2 protease on viral growth indicates that the NS3 is not active in the 
uncleaved NS2-3 form (108).  The temporal decrease in NS2-3 cleavage as the 




BVDV replication in tissue culture can lead to a dramatic cytopathic effect 
(CPE) beginning approximately 24 h post-infection.  Not all BVDV sequences are 
able to induce this effect, with many instead establishing a persistent infection 
without inducing cell death.  This observation has led to the division of BVDV 
strains into two biotypes, cytopathic (cp) and noncytopathic (ncp) (reviewed in 
142).  Interestingly, the efficiency of NS2-3 cleavage has been found to correlate 
with the ability of BVDV to kill cells in tissue culture.  While both cp and ncp 
viruses express large amounts of uncleaved NS2-3, only cp BVDV produces 
discrete NS3 in significant quantities.  Although ncp genomes were long thought 
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to be entirely deficient in NS2-3 cleavage, recent evidence has shown that ncp 
viruses do produce processed NS3, albeit at very low levels and only early in 
infection (108).  This reconciles with the observation that NS3 can only act in 
replication after its liberation from the NS2-3 precursor  (108).  In keeping with 
this role for discrete NS3 in replication, cp genomes accumulate RNA to higher 
levels than ncp viruses.  Interestingly, infectious virus titers do not differ 
significantly different between the biotypes, suggesting that RNA replication is not 
the limiting factor in virion production (108).   
The mechanism by which cleaved NS3 leads to cytopathogenicity is not 
understood.  Neither cleaved NS3 nor the high levels of RNA replication per se 
appear to be cytotoxic, since both phenotypes can be uncoupled from CPE by 
adaptive mutations in NS4B (163).  It has also been suggested that these 
mutations in NS4B may block apoptotic pathways, thereby masking the 
deleterious effects of overwhelming viral replication (Paulson M. and CMR, 
unpublished data).   
 
Pathogenesis 
The cell culture cytopathic phenotype has significance to disease 
progression in infected animals.  Whereas exposure of adult animals to BVDV 
often results in asymptomatic infection, calves infected in utero can become 
immunotolerant to and persistently infected with the virus (reviewed in 142).  
These calves may go on to develop fatal mucosal disease.  While ncp BVDV 
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alone can be isolated from asymptomatic animals, both cp and ncp viruses can 
be found in animals suffering from mucosal disease.  Since these viruses are 
antigenically related, and are nearly identical in sequence, cp BVDV is thought to 
develop from the ncp virus within the infected animal (142).  
cp BVDV genomes can arise in a variety of ways, all of which affect 
processing at the NS2/NS3 junction.  Cellular or viral insertions, deletions, and 
even point mutations have been found to give rise to NS3 expression and 
resulting cytopathogenicity (13, 16, 104, 136, 200).  NADL (National Animal 
Disease Laboratories), the American prototype cp BVDV, contains a 270-
nucleotide insertion in NS2 that potentiates the partial cleavage of NS2-3 (136).  
Sequencing of this insertion identified it as encoding a 90-amino acid portion of 
Jiv, the same J-domain chaperone required as an essential cofactor in NS2-3 
cleavage (171).  Removal of this insertion results in NADL Jiv 90-, an ncp BVDV 
strain in which NS2-3 remains predominantly uncleaved (136).  Portions of the 
Jiv coding sequence have subsequently been found in several other BVDV 
genomes isolated from diseased animals (148, 150).  Insertions of Jiv, as well as 
other insertions and mutations that increase NS2-3 cleavage, have been 
proposed to overcome the limitations of the titratable cellular cofactor (107).  The 
resulting insensitivity to the temporal down-regulation of replication, however, 
means that these viruses cannot establish persistent infections and ultimately kill 
their host  (107).    
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Infectious virus production 
Work in our laboratory has determined that NS2 and NS3, in the context of 
the uncleaved NS2-3 precursor, are essential for the production of infectious 
virus (2).  This additional role for these proteins coincides well with the observed 
accumulation of uncleaved NS2-3 late in infection, when progeny virions are 
produced (108).  Abrogation of uncleaved NS2-3 expression by insertion of either 
a Ubi monomer or an IRES between the two proteins led to complete processing 
of NS2-3 and prevented infectious virion formation without decreasing RNA 
replication (2).  Reintroduction of uncleaved NS2-3 either within the bicistronic 
genome, or in trans restored uncleaved NS2-3 expression and infectious particle 
production.  The mechanisms by which uncleaved NS2-3 functions in infectivity 
are not understood. 
NS2 and NS3 have essential functions at almost every stage of the viral 
life cycle, from inter-host transmission to the molecular mechanisms of 
replication.  The central importance of these proteins to Pestivirus replication and 
disease led us to dissect the determinants of one of their functions, that of 
infectious virus production.    
 
Results 
Development of a quantitative trans-complementation assay for NS2-3 
To better understand the role of uncleaved NS2-3 in infectious virus 
production, we investigated the minimal requirements for its activity. As a 
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convenient assay for such determinants, a trans-complementation system was 
developed.  Previous observations had suggested that an NS2-3-deficient 
genome could be rescued by ectopic expression of the uncleaved protein. We 
used this observation as the basis of a quantitative trans-complementation 
assay.    
The uncleaved NS2-3-deficient genome constituted the full-length NADL 
Jiv90- genome with an encephalomyocarditis virus (EMCV) IRES inserted 
between NS2 and NS3 (Fig 5-2A).  The first cistron consists of the authentic 
BVDV IRES followed by Npro and the structural proteins up to NS2; the second 
cistron is modified by the addition of a second copy of Npro followed by the coding 
sequences for NS3 to NS5B.  The autoproteolytic activity of Npro allows the 
authentic NS3 amino-terminus to be created, which is essential for efficient 
replication (203).  The second cistron is sufficient for autonomous replication and 
is similar to naturally occurring BVDV subgenomes (sg), which possess large 
deletions of the structural proteins.  The uncleaved NS2-3-deficient genome was 
therefore termed Npro-NS2/sg (Fig 5-2A).     
Ectopic expression of NS2-3 was achieved using a second bicistronic 
genome.  In this genome, Npro-p7-NS2-NS3-NS4A is encoded in the first cistron 
under the control of the BVDV IRES (Fig 5-2A).  Npro is required for efficient 
translation and cleaves itself from the amino-terminus of p7 (149).  The second 
cistron, driven by the EMCV IRES, is identical to that of Npro-NS2/sg.  This 
construct was termed p7-NS2-NS3-4A/sg (Fig 5-2A).  
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Fig 5-2.  Development of a quantitative trans-complementation assay for 
NS2-3.  (A) Schematics of mono and bicistronic genomes.  Wild-type NADL and 
NADL Jiv90-, top.  Uncleaved NS2-3 deficient genome, middle, and p7-NS2-3-4A 
expressing genome, bottom.  (B) RNA replication of Npro-NS2/sg and p7-NS2-3-
4A/sg at 30 h post-transfection as measured by NS3 expression.  Mean and SEM 
of duplicate experiments are shown.  (C) Intracellular protein expression at 30 h 
post-electroporation.  Western blot for NS3-containing species using polyclonal 
Ab G40, top panel, and for β-actin, lower panel.  (D) Quantification of infectious 
virus production at 30 h post-electroporation by immunofluorescence, left, or flow 
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In vitro generated RNA transcripts of each genome were electroporated 
into MDBK cells.  The replication efficiency of each genome was determined at 
30 h post-electroporation by immunostaining for NS3 and quantification of 
positive cells by flow cytometry (FACS).  Both Npro-NS2/sg and p7-NS2-NS3-
4A/sg replicated to similar levels (Fig 5-2B).  To verify that p7-NS2-NS3-4A/sg 
expressed the uncleaved NS2-3 protein, cell lysates harvested 24 h post-
electroporation were analyzed by Western blot with an anti-NS3 polyclonal Ab 
(G40, ref 42, 41).   NADL-transfected cell lysates were used as a marker for 
native NS2 and NS2-3.  Uncleaved NS2-3 was expressed by p7-NS2-NS3-4A/sg, 
but not by Npro-NS2/sg (Fig 5-2C).  Consistent with the cytopathogenicity of 
NADL, and the slight CPE induced by Npro-NS2/sg, the β-actin loading control 
was slightly reduced in these lanes (Fig 5-2C). 
Infectious virus produced by the trans-complementation of NS2-3 is 
incapable of subsequent rounds of infection since only a single genome is 
packaged in the infectious particle.  The standard plaque or focus forming assays 
for viral titer depend on the amplification of an infectious unit by spread to 
neighboring cells and could therefore not be used to quantify the 
pseudoinfectious virus released by the trans-complementing genomes.  To 
overcome this, we developed a FACS-based assay for infectivity.  Clarified cell 
culture supernatants were used to infect naïve MDBK cells.  At 30 h post-
infection, the cells were trypsinized, fixed, and stained for NS3 expression (mAb 
184, ref 47).  The proportion of cells expressing NS3, each assumed to represent 
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a single infectious event, was then determined by FACS (Fig 5-2D, right panel).  
NS3-positive cell quantification by FACS correlated well with visualization of 
immunofluorescently labelled cells (Fig 5-2D, left panel).  Using this approach, 
the titer of pseudoinfectious virus released from Npro-NS2/sg and p7-NS2-NS3-
4A/sg co-electroporated cells was determined to be 1 x 105 infectious units/ml 
(IU/ml, Fig 5-2D).  Npro-NS2/sg or p7-NS2-NS3-4A/sg alone were not expected to 
produce infectious virus, as these genomes lack uncleaved NS2-3 and envelope 
proteins, respectively.  Accordingly, infection of naïve cells with supernatants 
collected 48 h after electroporation with only Npro-NS2/sg or p7-NS2-NS3-4A/sg 
revealed levels of virus below the limit of detection (500 IU/ml, Fig 5-2D).   
To rule out the possibility that recombination between the co-
electroporated genomes was responsible for the recovered virus, the 
supernatants were passaged on MDBK cells.  Recombinant genomes would be 
expected to increase in titer during passaging.  After the first passage, however, 
virus was undetectable, suggesting recombinants were not present (data not 
shown).  These data suggested that an NS2-3 deficient genome could be 
rescued by expression of the p7-NS2-NS3-4A polyprotein fragment in trans, and 
that this infectivity could be quantified using a FACS-based assay. 
 
p7 is not required in cis for NS2-3 function 
p7 is a small hydrophobic protein that immediately precedes NS2 in the 
polyprotein and has also been shown to be essential for Pestivirus infectious 
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virion production (76); its mechanism of action in infectivity is not understood.  To 
determine if p7 was required in cis with NS2-3 for the activity of the uncleaved 
protein in infectious virus production, we expressed the NS2-3-4A polyprotein 
fragment in MDBK cells.  A bicistronic BVDV genome was created in which the 
first cistron, driven by the BVDV IRES, encoded 39 amino acids of Npro, a Ubi 
monomer, and the NS2 to NS4A region of the NADL Jiv90- genome.  The 
fragment of Npro was included to allow efficient translation from the BVDV IRES, 
and the Ubi monomer to direct correct processing at the amino-terminus of NS2 
(149).  The downstream cistron, expressed from the EMCV IRES, is identical to 
that of Npro-NS2/sg.  The resulting construct was termed Ubi-NS2-NS3-4A/sg (Fig 
5-3A).  
In vitro transcribed RNA of Ubi-NS2-NS3-4A/sg was electroporated into 
MDBK cells alone, or in combination with Npro-NS2/sg.  Replication efficiencies 
were determined at 30 h post-electroporation by FACS-based quantification of 
NS3 positive cells. Ubi-NS2-NS3-4A/sg replication was equivalent to that of Npro-
NS2/sg and p7-NS2-NS3-4A/sg (Fig 5-3B).  Levels of NS2-3 protein expression 
were compared by Western blot analysis of cell lysates collected 24h post-
electroporation.   Similar to p7-NS2-NS3-4A/sg, Ubi-NS2-NS3-4A/sg produced 
NS2-3 and NS3 at levels comparable to NADL; Npro-NS2/sg produced only 
cleaved NS3 (Fig 5-3C).   
Infectious virus production at 48 h post-electroporation was assessed by 
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Fig 5-3. p7 is not required in cis for NS2-3 function.  (A) Schematics of
bicistronic genomes.  NS2-3 deficient genome, top, p7-NS2-3-4A-expressing
genome, middle, and NS2-3-4A-expressing genome, bottom.  Ubi, black box,
designates a ubiquitin monomer.  Infectious titers produced by co-transfection
of indicated genome with Npro-NS2/sg are shown, right.  Infectious units/ml 
(IU/ml) were calculated by flow cytometry analysis of infected cells for NS3
expression. (B)  Replication of bicistronic genomes at 30 h post-electroporation,
as calculated by flow cytometry for NS3 expression.  Mean and SEM of 
quadruplicate experiments are shown.  (C) Expression of NS3-containing 
protein products at 24 h post-electroporation.
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Neither Npro-NS2/sg, p7-NS2-NS3-4A/sg, nor Ubi-NS2-NS3-4A/sg alone were 
able to produce infectious virus (data not shown). p7-NS2-NS3-4A/sg or Ubi-
NS2-NS3-4A/sg, however, each trans-complemented Npro-NS2/sg with similar 
efficiencies, producing titers of 9.3 x 105 and 6.4 x 105 IU/ml, respectively (Fig 5-
3A).  These data suggested that p7 is not required in cis with NS2-3 for its 
function in infectious virus production.  
 
NS4A is required in cis for optimal NS2-3 function 
To further understand the minimal polyprotein region required for 
uncleaved NS2-3 function, we investigated whether NS4A was required in cis 
with NS2-3 for infectious virus production.  Bicistronic genomes p7-NS2-3-4A(Δ9-
64)/sg and p7-NS2-3/sg were created to express p7-NS2-NS3 in the absence of 
NS4A (Fig 5-4A).  p7-NS2-3-4A(Δ9-64)/sg expressed Npro followed by p7, NS2, 
NS3, and the amino-terminal eight amino acids of NS4A under the control of the 
BVDV IRES.  p7-NS2-3/sg expressed Npro followed by p7, NS2, NS3 and a stop 
codon, completely deleting NS4A.  Both genomes contained a second cistron 
identical to that of Npro-NS2/sg, the expression of which was directed by the 
EMCV IRES.   
Replication of p7-NS2-3-4A(Δ9-64)/sg and p7-NS2-3/sg were assessed by 
FACS analysis of NS3 expression in cells at 30 h post-electroporation (Fig 5-4B).  
Although p7-NS2-3-4A(Δ9-64)/sg appeared to replicate slightly less efficiently 
than p7-NS2-3/sg, neither was significantly lower in NS3 accumulation than the 
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Fig 5-4. Determinants of NS2-3 function.  (A) Schematics of bicistronic 
genomes.  NS2-3 deficient genome, top, and genomes expressing the indicated 
regions of the NADL Jiv90- polyprotein.  S1842A, black line, designates a lethal 
serine to alanine change in the NS3 protease active-site.  Infectious titers 
produced by co-transfection of the indicated genome with Npro-NS2/sg are shown, 
right.  Infectious titers (IU/ml) were calculated by flow cytometry analysis of 
infected cells for NS3 expression. (B) Replication of bicistronic genomes at 30 h 
post-electroporation, as calculated by flow cytometry for NS3 expression.  Mean 
and SEM of duplicate experiments are shown.  (C) Expression of NS3-containing 
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parental construct, p7-NS2-3-4A/sg.  Analysis of protein expression at 24 h post-
electroporation indicated that both p7-NS2-3-4A(Δ9-64)/sg and p7-NS2-3/sg 
expressed uncleaved NS2-3 in addition to NS3 (Fig 5-4C).  A slight difference in 
migration of NS2-3 was detected in the case of p7-NS2-3-4A(Δ9-64)/sg, 
suggesting that the residual eight amino acids of NS4A had not been cleaved by 
the NS3 protease.   
Infectious virus production at 48 h post-electroporation was measured by 
FACS analysis of cells infected with clarified culture supernatants.  In accordance 
with the absence of structural proteins, neither p7-NS2-3-4A(Δ9-64)/sg nor p7-
NS2-3/sg alone produced infectious virus (data not shown).  Both genomes, 
however, were able to rescue infectivity of Npro-NS2/sg, with titers reaching 7.4 x 
103 IU/ml (p7-NS2-3-4A(Δ9-64)/sg) and 2.1 x 104 IU/ml (p7-NS2-3/sg).  Trans-
complementation of Npro-NS2/sg by p7-NS2-3/sg, although slightly more efficient 
than by p7-NS2-3-4A(Δ9-64)/sg, produced almost 100-fold less infectivity than 
when NS2-3 was expressed in the context of p7-NS2-3-4A/sg (Fig 5-4A).  These 
results suggested that the presence of NS4A in cis is required for optimal 
function of NS2-3, and that an uncleavable fragment of NS4A may interfere with 
this function.    
 
 
NS3 protease activity is not required for NS2-3 function 
 The serine protease activity of NS3 is required for polyprotein processing 
and RNA replication.  To determine if this enzymatic activity was also required for 
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the function of NS2-3 in infectivity, we created p7-NS2-3(S1842A)-4A/sg.  This 
genome is identical to p7-NS2-3-4A/sg but with a mutation of the NS3 active-site 
serine (1842) to alanine (Fig 5-4A, ref 201).  Replication of p7-NS2-3(S1842A)-
4A/sg at 30 h post-electroporation was similar to that of the parental genome, p7-
NS2-3-4A/sg (Fig 5-4B).  Western blot analysis of cell lysates harvested at 24 h 
post-electroporation indicated the expression of NS3 in addition to NS2-3-4A (Fig 
5-4C).  NS4A was not cleaved from NS2-3 as the NS3 protease activity is 
required for this processing event.  Assay for infectious virus production at 48 h 
post-electroporation revealed that p7-NS2-3(S1842A)-4A/sg was not capable of 
trans-complementing Npro-NS2/sg infectivity, leading to background levels of NS3 
expression by both FACS analysis and direct visualization of immunofluorescent 
staining (Fig 5-4A and data not shown).      
We hypothesized that the retention of NS4A on the carboxy-terminus of 
NS2-3 may be deleterious to its function.  We therefore created p7-NS2-
3(S1842A)/sg, which is identical to p7-NS2-3(S1842A)-4A/sg but with a complete 
deletion of NS4A (Fig 5-4A).  Replication of p7-NS2-3(S1842A)/sg at 48 h post-
electroporation was equivalent to that of p7-NS2-3-4A/sg (Fig 5-4B) and Western 
blot analysis of cell lysates at 24 h post-electroporation indicated that NS3 and 
NS2-3 were expressed (Fig 5-4C).  Whereas no infectious virus was produced 
from MDBK cells harboring p7-NS2-3(S1842A)/sg alone (data not shown), 
coexpression with Npro-NS2/sg resulted in a titer of 2.4 x 104 IU/ml (Fig 5-4A).  
This level of infectivity was similar to that produced by co-electroporation of p7-
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NS2-3/sg with Npro-NS2/sg, a genome identical to p7-NS2-3(S1842A)/sg except 
for the activity of the NS3 protease (Fig 5-4A).  These results suggested that, 
apart from its role in cleaving NS2-3 from NS4A, the protease activity of NS3 is 
not absolutely required for NS2-3 function in morphogenesis.   
 
Discussion 
All positive-sense RNA viruses express their genomes as long 
polyproteins that must be cleaved to liberate the individual gene products.  These 
cleavage events are often carefully regulated and processing intermediates can 
mediate functions unique from the final cleavage products (15, 193).  In BVDV-
infected cells, the NS2-3 uncleaved precursor accumulates to high levels.  Work 
in our laboratory determined that this cleavage intermediate performs an 
essential function in infectious virus production, which could not be mediated by 
either of the individual proteins (2).  This strict requirement for NS2-3 in the viral 
life cycle is supported by the observation that the uncleaved protein is maintained 
in all autonomous BVDV genomes, despite the increased processing at the 
NS2/NS3 junction in many cp BVDV strains.  Preservation of the protein is 
achieved either by incomplete processing at this junction or by duplication of the 
uncleaved protein elsewhere in the genome.  The selective pressure towards 
incomplete NS2-3 processing is illustrated by the Osloss strain of BVDV, a 
naturally occurring isolate that encodes a Ubi monomer inserted between NS2 
and NS3 (138).  Cleavage of Ubi by the cellular enzyme Ubi carboxy-terminal 
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hydrolase is not complete in this context, and is thought to be inhibited by two or 
more mutations in the cellular insertion (46, 137, 202).  The importance of 
uncleaved NS2-3 encoded by genomic duplications is seen in the JaCp strain.  
This cp BVDV genome contains an insertion of a portion of light chain 3 of 
microtubule-associated proteins 1A and 1B (LC3*) upstream of NS3, causing the 
complete release of NS3 from the polyprotein (140). The genome also encodes a 
duplication of NS2 up to the amino-terminal part of NS4B; removal of the 
duplicated region resulted in a genome that did not express uncleaved NS2-3 
and was not infectious (140).  
Genomic duplications arising to compensate for complete processing of 
NS2-3 induced by cellular insertions offer information about the minimal 
sequences required for uncleaved NS2-3 activity.  The results of our trans-
complementation assays suggested that the expression of NS4A in cis was 
important for optimal NS2-3 function.  Interestingly, duplications in cp genomes 
encompass not only NS2-3, but also the entire NS4A coding sequence (8, 13, 14, 
140, 162, 161).  This may indicate a requirement for the protease domain of NS3 
to interact with its cofactor, NS4A, in order for NS2-3 to function optimally.  
Although NS4A is expressed from the second cistron in all the bicistronic 
constructs, this protein may be sequestered by NS3 encoded immediately 
upstream, and therefore be unavailable for interaction with NS2-3.   
Although the NS3 protease cofactor, NS4A, was found to be important for 
NS2-3 function, the catalytic activity of the protease did not appear to be required 
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for virion production (summarized in Fig 5-5).  It is possible that the NS3 protease 
is not active in the context of wild-type NS2-3, a hypothesis supported by the 
report that NS3 must be cleaved from NS2 in order to function in replication 
(108).  This, however, is inconsistent with reports that NS3-4A processing occurs 
primarily in cis, a result supported by our finding that a mutation in the NS3 
protease active-site prevented NS2-3 processing from NS4A despite the 
presence of an active NS3 protease in the downstream cistron. Uncoupling of the 
proteolysis and replication activities of NS3 has been reported, as truncations of 
NS3 that are lethal for replication can allow polyprotein processing to occur (201, 
203).  Cleavage at the NS3-4A junction was found to be the least sensitive to 
NS3 modification (201).  Therefore, while the NS3 protease activity likely is active 
in the context of NS2-3, this activity is not required for the function of the 
uncleaved protein in infectivity.   
In two constructs reported here NS4A sequences could not be cleaved 
from NS2-3, either due to inactivation of the protease (p7-NS2-3(S1842A)-4A/sg), 
or because of NS4A truncation (p7-NS2-3-4A(Δ9-64)/sg) (45).  These genomes 
were severely impaired in their ability to trans-complement infectivity of Npro-
NS2/sg.  One possibility for this phenotype is that a general conformational 
change or misfolding of NS3 might be induced by the carboxy-terminal extension.  
Alternately, the NS3-4A junction may be recognized by the protease but retained 
in the active-site in the absence of processing.  Studies of the HCV NS3 protease 


















Fig 5-5.  Summary of determinants of NS2-3 functions in infectious
virus production.  (A) Putative topology diagram of the p7 to NS4A 
region of the BVDV polyprotein.  NS3 active-site S1842 is designated 
by a star.  (B)  Minimal regions of the polyprotein required for 
NS2-3 function.  
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substrates (189).  The latter hypothesis would suggest that the NS3 active-site 
cleft, but not its catalytic activity, is required for NS2-3 function (Fig 5-5).  These 
studies were conducted before the discovery of a second protease activity in NS2 
(108).  The contribution of NS2 enzymatic activity to NS2-3 function, therefore, is 
not known.   
While NS4A was required in cis with NS2-3 for optimal infectivity, p7 was 
not (Fig 5-5).  This result was surprising given the presumed role of p7 as a 
signal sequence for NS2 (76).  Interestingly, the HCV NS2 protein, which is also 
essential for infectious virus production, was similarly functional in the absence of 
the p7-derived signal sequence (90).  For HCV, although the carboxy-terminus of 
p7 has been shown to act as a signal sequence (32), NS2 is targeted to 
membranes in its absence (226).  These results suggest that proteins encoded 
by both these viruses may have redundancies in their mechanisms of membrane 
targeting.    
We have developed a quantitative trans-complementation system for NS2-
3 and used it to investigate the determinants of uncleaved NS2-3 involved in 
infectious Pestivirus production.  The optimal activity of NS2-3 in this role 
requires a close genetic association with the protease cofactor, NS4A, but does 
not require the catalytic activity of the protease.  NS2-3 function does not require 
cis-expression of p7, or the signal sequence it provides.  The indication of a role 
for BVDV NS2-3-4A proteins in infectious virus production adds to the 
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accumulating evidence that this region of the polyprotein performs essential 





 Chapter 6:  Discussion 
 
 Production of an infectious virion represents the culmination of numerous 
processes initiated by expression of the viral genome within the host cell 
environment.  Virus morphogenesis itself involves numerous interactions 
between viral, and often cellular, components, disruption of any one of which 
could lead to novel therapeutic agents.  We have investigated the determinants 
of infectious virion production in the Pestiviruses and Hepaciviruses.  As well as 
the importance of the structural building blocks of the virion, we have found 
numerous indications that nonstructural proteins are integral components of the 
assembly pathway.        
 
Structural and nonstructural proteins in infectious virus production 
 
Role of the capsid proteins 
 To investigate the mechanisms of Flaviviridae assembly, we studied an 
important virion structural component, the viral capsid proteins.  Biochemical 
studies of BVDV capsid suggested that it is a nonspecific RNA condensing agent, 
a hypothesis that was supported by its functional replacement of such a protein in 
vivo.  We hypothesize that the Pestivirus capsid does not form a discrete shell 
around the RNA genome, but rather complexes with it to condense, neutralize, 
and package the nucleic acid molecule into the budding particle.  Consistent with 
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this hypothesis, Flavivirus particles have been reported to contain nucleoprotein 
complexes of undefined symmetry, rather than an icosahedral core; structures of 
Pestivirus and Hepacivirus particles have not been determined.  In addition to a 
structured carboxy-terminal domain, HCV core possesses a basic amino-terminal 
region that is disordered in solution (106, 25).  We propose this domain to be 
functionally equivalent to the BVDV capsid protein.  Consistent with this 
hypothesis, studies of recombinant core proteins encompassing this flexible 
domain demonstrated RNA binding and aggregation behaviors similar to BVDV 
capsid (105, CLM and CMR, unpublished observations).   
Alanine-scanning mutagenesis of HCV core provided an opportunity to 
examine the properties of the amino-terminal domain in the context of an 
infectious virus.  Although a portion of the highly basic domain (residues 1-56) 
was omitted from our analysis, mutation of amino acids 57 through 104 did not 
disrupt the stability of the core protein, consistent with the predicted flexibility of 
this region.  It was somewhat surprising, however, that these mutations were 
deleterious to infectious virus production, since our model would predict that 
significant changes could be tolerated as long as enough basic residues were 
retained.  Since the efficiency of the HCVcc system is relatively low, it is possible 
that J6/JFH infectivity is not robust enough to tolerate even small perturbations in 
the RNA binding region.  Alternately, residues prior to amino acid 57 may be the 
primary RNA condensing sequences, and those in the region of mutagenesis 
might be involved in additional interactions instead of, or in addition to, charge 
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neutralization within the particle.  Our finding that incorporation of mutant core 
proteins did not compromise virion stability suggested that limited changes in this 
region did not affect efficient constraint of the RNA genome, consistent with the 
proposed flexibility of this function.   
 The presence of nonspecific RNA binding sequences in the capsid 
proteins may have additional relevance to the viral life cycle.  Both Pestiviruses 
and Hepaciviruses are capable of establishing chronic infections.  This ability to 
persist for months or years is dependent on an evasion of host defenses, 
including innate cellular responses against markers of viral infection such as 
double stranded RNA (dsRNA).  HCV is thought to combat these innate defenses 
through several mechanisms, including NS3-mediated cleavage and inactivation 
of two dsRNA response factors, Cardiff and TRIF (reviewed in 62).  Core itself 
has been reported to up-regulate an inhibitor of interferon signaling, SOCS-3 
(22).  The nonspecific RNA binding abilities of the capsid proteins might be 
envisioned to mask intracellular viral RNA as an additional mechanism of innate 
immune system evasion. 
The Flaviviridae capsid proteins have the critical task of containing the 
genomic RNA within the particle and may play additional roles in managing 
replicating RNA within the cell.  Our studies of BVDV capsid suggest that a 
flexible, basic sequence alone can accomplish this.  HCV and Flavivirus capsid 
proteins consist of a similarly disordered arm coupled to a globular domain.  The 
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requirement for this additional domain may relate to differing mechanisms of 
assembly or to further additional functions for the proteins (165).  
 
Role of the nonstructural proteins 
While the capsid proteins provide the structural components of the virion, 
such a complex macromolecular assembly likely requires orchestration by 
accessory factors.  Converging evidence from each of the Flaviviridae genera 
implicates nonstructural proteins in infectious particle production.  The NS2 and 
NS3 proteins of all these viruses appear to be architects of assembly.  We report 
that for BVDV, uncleaved NS2-3 is essential for infectivity, and that the NS3 
cofactor, but not the protease catalytic activity, is important for this function.  The 
HCV NS2 protein is also essential in virion morphogenesis, functioning at an 
early step, prior to the accumulation of intracellular infectious virus (90).  
Consistent with this, we identified a compensatory mutation in NS2 that rescued 
a core mutant from a block early in infectious virus assembly.  Although 
uncleaved NS2-3 is not required for HCV infectivity (90), rescue of a second core 
mutant by a weak compensatory mutation in NS3 suggested that the processed 
protein might nonetheless be involved in infectious virion production.   
The viruses of the genus Flavivirus do not encode an autoprotease 
equivalent to NS2.  Amino-terminal to NS3 are two hydrophobic proteins that 
span the membrane several times.  One of these, NS2B, is the NS3 protease 
cofactor, the other, NS2A, is important for infectious virus production (103).  The 
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NS2B-3 protease cleaves NS2A at a cryptic internal site, creating a truncated 
form of the protein termed NS2Aα (153).  Mutational analysis of this cleavage site 
revealed that NS2Aα per se was not required for infectivity, but that the basic 
sequence in this region was essential for the formation or budding of 
nucleocapsids (103).  Second-site mutations in the helicase domain of NS3 were 
found to suppress mutations in this motif and restore virus production, suggesting 
a required interaction between NS2A and NS3 in Flavivirus morphogenesis (103).  
Interactions between NS3, its protease cofactor, and an associated integral 
membrane protein may therefore be a common theme in nonstructural protein 
requirements for Flaviviridae infectious virion production. 
The p7 protein of Pestiviruses and Hepaciviruses is another nonstructural 
protein essential for infectious virus production (76, 179, 90).  This small 
hydrophobic protein is incompletely processed by signal peptidase, leading to an 
accumulation of uncleaved E2-p7 (114, 54).  This association with an envelope 
protein suggested p7 might be incorporated into virions as a minor component.  
This precursor, however, is not essential for BVDV or HCV infectivity, and p7 has 
never been detected in Pestivirus particles (205); studies of HCV virions are 
ongoing.  HCV p7 has been found to function early in infectious virion production, 
similar to NS2 (90).  Optimal infectivity of HCV intergenotypic chimeras requires 
homology between regions of p7 and NS2, suggesting that these nonstructural 
factors may work in concert (159).  Uncleaved p7-NS2 precursors also 
accumulate in BVDV and HCV infected cells (54, 114).  The finding that this 
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precursor is not essential for HCV infectivity, however, as well as our 
observations that BVDV p7 is not required in cis with NS2-3 indicate that the 
putative association between these pathways is not a result of unprocessed 
forms.  Like the other nonstructural proteins implicated in morphogenesis, we 
found that certain core mutations could be rescued by changes in p7. 
Flaviviridae nonstructural proteins engineer the production of an infectious 
virion.  While the NS2 and NS3 proteins of all Flaviviridae appear to be essential 
for infectivity, only the Pestivirus and Hepacivirus genera have a requirement for 
p7.  The hypothesis that p7 and NS2 may function together early in particle 
morphogenesis coincides well with our finding that mutations in either of these 
proteins rescued core mutants after localization to putative sites of budding, but 
before the assembly of an infectious particle.   
 
Mechanisms of nonstructural protein action 
The mechanisms of nonstructural protein involvement in Flaviviridae 
infectious particle production are not understood.  During the assembly of an 
intricate macromolecular complex such as an infectious virion, however, 
numerous roles for nonstructural cofactors can be envisioned (Fig 6-1).  
 
Enzymatic activities    
 Several of the nonstructural proteins implicated in Flaviviridae 
morphogenesis have enzymatic activities.  Pestivirus and Hepacivirus NS2 
Fig 6-1.  Nonstructural proteins and virion morphogenesis.
Nonstructural  proteins speculated  to act by each  mechanism are 






















proteins are autoproteases, and the NS3 sequences of all Flaviviridae have 
protease, helicase, and NTPase activities.  It is an intriguing possibility that these 
enzymatic activities may function in viral assembly as well as in nonstructural 
protein processing and replication.  
 The NS2 protease mediates a single cleavage at its own carboxy-
terminus.  The recent crystal structure of HCV NS2 revealed that this dedicated 
protease activity results from retention of the carboxy-terminal residue in the 
active-site after cleavage, thereby inactivating the enzyme (122).  Consistent with 
this, the catalytic activity of NS2 is not essential for infectious virus production, 
although the protease domain itself is required (90).  BVDV NS2 has been 
predicted to undergo similar product inhibition (109), although the role of the 
autoprotease activity in assembly has not been determined.   
 In Flaviviruses, the protease activity of NS3, with its cofactor NS2B, 
mediates cleavage of the capsid protein from its membrane anchor, and is thus 
essential for infectious virus production.  Inspection of the capsid protein 
sequences from Pestiviruses and Hepaciviruses revealed the presence of NS3 
protease recognition sites in the corresponding membrane anchors (180, 2).  
Subsequently it was found that a host enzyme, SPP, and not NS3, was 
responsible for processing this region of capsid.  This finding was confirmed by 
mapping the carboxy-terminal amino acid of the virion associated Pestivirus 
capsid protein to alanine 90, three amino acids after the predicted NS3 cleavage 
site (78).  In HCV, the carboxy-terminus of the mature capsid protein is not 
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known, leaving the formal possibility that NS3 may clip a few additional residues 
after SPP processing has occurred.  Mutagenesis of the NS3-recognition 
sequence in the HCV core protein, however, did not support this hypothesis, 
since a mutation previously reported to abolish NS3 cleavage (100) did not impair 
infectivity.   
 Although the viral protease activities do not appear to influence infectivity, 
the helicase activity of NS3 might be envisioned to participate.  In Flaviviruses, 
NS2A and the NS3 helicase are proposed to work in concert to mediate 
nucleocapsid incorporation into budding particles (103).  Compensatory 
mutations in NS3 that partially rescued an HCV core mutant mapped to the linker 
between protease and helicase domains, and thus could be predicted to affect 
either activity.  The NS3 helicase is important for unwinding RNA secondary 
structures during replication.  This ability might also facilitate packaging of a 
genomic RNA substrate.  In addition to secondary structure unwinding, an ability 
of RNA helicases to dissociate proteins from nucleic acid has been demonstrated 
(57).  Removal of replication or translation machinery from the genomic RNA is 
likely to be an important prerequisite for assembly.   
 
Regulation of replication and assembly  
Although the catalytic activities of the nonstructural proteins may not be 
required for infectious particle production, these enzymes are essential for 
replication.  This dichotomy suggests that nonstructural sequences might be 
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important in regulating the switch from active replication to virion production.  
This hypothesis is illustrated by the findings that BVDV NS3 alone is active in 
replicating the viral genome, whereas uncleaved NS2-3 is required for infectious 
virus production.  The kinetics of Pestivirus NS3 and NS2-3 expression closely 
mirrors the switch from active replication to infectious particle production.   
In Flaviviruses, only genomes capable of autonomous replication are 
substrates for the packaging machinery, suggesting replication and assembly are 
coupled processes (95).  It has been hypothesized that this linkage may arise 
from a physical connection between membranous replication and assembly sites 
(95, 126).  NS2A colocalizes with replication complexes (125) and is essential for 
infectious virus production (103), suggesting it may mediate a switch between the 
two processes.  The ability of NS2A to bind RNA has led to the hypothesis that 
this integral membrane protein might channel genomic substrates out of 
membrane bound replication complexes and to the sites of packaging (125).  
Since NS3 binds RNA, and NS2 is an integral membrane protein, a similar 
mechanism might be proposed of the functions of these proteins in Pestivirus and 
Hepacivirus virion morphogenesis.   
 
Ion channels 
 Viroporins are a group of small, hydrophobic, virally encoded proteins that 
increase membrane permeability.  While some of these proteins, such as 
influenza virus M2, are structural, most are not major components of the virion; 
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all, however, are involved in enhancing infectious particle production (reviewed in 
66).  As well as influenza virus M2, viroporins include HCV and BVDV p7, HIV 
Vpu, Alphavirus 6K, and poliovirus 2B.  Oligomerization and ion channel activities 
of these proteins have been observed by insertion of these sequences into planar 
lipid membranes, liposomes, and Xenopus oocytes (66).  With the exception of 
M2, the relevance of the in vitro ion channel activity to a role in infectious particle 
production is not known.  The M2 protein has dual functions in the influenza virus 
life cycle.  It protects the glycoproteins from low-pH mediated inactivation during 
their transit though the trans-Golgi network, and it increases the permeability of 
the virion to ions, facilitating dissociation of the particle during entry.  HCV and 
BVDV particles also transit the low-pH compartments of the secretory pathway, 
suggesting that the p7 proteins of these viruses may be important in protecting 
the exposed glycoproteins from undergoing premature acid-induced fusion.  In 
conflict with this hypothesis are the findings that both HCV and BVDV are acid 
resistant until they are triggered by unknown factors during entry, suggesting 
protection from low pH may not be necessary (209).  In addition, recent studies 
have indicated that HCV p7 is essential for early assembly events, indicating that 
a putative role as an ion channel in egress cannot be its only function (90).   
 
Membrane rearrangements  
 In cellular vesicle budding systems, such as endocytosis or intracellular 
vesicular transport, an array of specialized proteins are required to induce 
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membrane curvature and vesicle fission (reviewed in 135).  In addition to possibly 
recruiting such cellular proteins to assist in virus budding, structural or 
nonstructural proteins themselves might be envisioned to induce membrane 
rearrangements.  As well as possible roles for ion channel activities in entry and 
egress, modifications of membrane potential have been suggested to induce 
instabilities in the bilayer, which might facilitate budding (26, 184).  A role for p7 
in membrane adjustments would reconcile with data that it functions early in HCV 
assembly (90).  The HCV NS2 protease domain, which is also essential for early 
morphogenesis, forms a crescent shaped dimer (122).  Interestingly, this kinked 
conformation, and attached amino-terminal membrane-associated helices, 
resembles the membrane curvature-inducing structure of the 
bin/amphiphysin/rvs-homology (BAR) domain (158).  A function for NS2 in 
creating membrane curvature would be consistent with our finding that an alanine 
to proline mutation in one of the predicted amino-terminal helices rescued the 
infectivity of a core mutant.  In this model, the proline would kink the putative 
helix, increasing force on the membrane and augmenting budding efficiency.   
 
Binding to cellular factors  
 With the exception of the host proteases, signal peptidase and SPP, 
cellular factors required for Pestivirus or HCV assembly and release have not yet 
been identified.  In other viral systems the host cell environment is an integral 
cofactor in infectious particle production.  The involvement of the secretory 
 176 
pathway and the requirement for cellular membrane rearrangements for 
Flaviviridae morphogenesis suggests the involvement of many host factors, any 
number of which could be targets of recruitment, inhibition, or regulation by viral 
proteins.  During HIV infection of certain cell lines, the nonstructural protein Vpu 
is known to increase infectious virus production by interactions with at least two 
cellular factors.  Vpu is a small, integral membrane protein that has been 
classified as a viroporin.  Vpu does not localize to sites of assembly, does not 
interact with the structural proteins, and does not incorporate into virions (152).  
The enhancement of infectivity mediated by Vpu is a result of modulation of 
cellular protein functions.  The first mechanism of Vpu action is to down-regulate 
expression of the HIV receptor, CD4, on the cell surface by interacting with the 
receptor in the ER and targeting it for degradation. This prevents secreted 
particles from re-entering the infected cell and allows dissemination of the 
infection (26).  In an independent role, Vpu ensures release of mature viral 
particles from the plasma membrane by counteracting an inhibitory cellular factor 
that promotes tethering (152).  This cellular factor, the identity of which is not 
known, has been hypothesized to be a membrane protein that becomes 
incorporated into virions and adheres to the plasma membrane (152).   
 
Scaffolding 
Many double stranded DNA (dsDNA) viruses require scaffolding proteins 
to assist in assembly (reviewed in 49).  These nonstructural proteins associate 
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transiently with the forming viral particle but are not present in the mature 
infectious virion.  Scaffolding proteins catalyze assembly through a variety of 
mechanisms.  A Herpesvirus scaffolding protein associates with assembly 
intermediates and transports them to the sites of particle construction, thereby 
promoting nucleation events.  Several phage scaffolding proteins mediate 
associations between structural components, often bringing subunits into close 
proximity allowing conformational switches to occur, which then stabilize the 
interactions.  Many capsid subunit proteins have intrinsically flexible regions that 
provide the conformational variability necessary in building a virion shell; some 
scaffolding proteins act as chaperones, managing this intrinsic disorder until the 
appropriate interactions can be made.  Several scaffolding proteins of the dsDNA 
phages form internal or external bracing structures, ensuring a virion shell of the 
correct size and shape is formed.  Internal scaffolding proteins usually exit the 
shell as the genomic DNA is packaged.  
Our finding of genetic interactions between HCV core and p7, NS2, and 
NS3 might indicate the importance of transient physical interactions.  In addition 
to the proposed interaction with core, NS2 has also been reported to interact with 
E2 (183).  Such interactions might point to a role for Flaviviridae nonstructural 
proteins in scaffolding structural protein associations or in transport of virion 
building blocks to the sites of assembly. In addition to direct frameworking 
functions, the ability of BVDV NS2 to bind a cellular chaperone protein might 
indicate a function in recruiting host cell scaffolding machinery (171).   
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Conclusions 
 We have investigated Flaviviridae infectious virus production from two 
convergent perspectives.  The virion building blocks, the capsid proteins, have 
been found to consist of RNA condensing regions and structured domains of 
various relative proportions.  Nonstructural protein domains required for 
infectious particle production have been identified, and the importance of these 
proteins at early events in morphogenesis has been highlighted.  Investigations 
of Pestivirus, and especially Hepacivirus, infectivity have long been hampered by 
low yields of virus in tissue culture.  With the advent of a new era of HCV 
research, these complementary elements of infectious particle assembly can 
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